Major coronary heart disease event

I9_CHD

intermediate coronary syndrome: Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Main diagnosis only: side diagnoses are not checked. Registry filters: Hospital discharge: ICD-10 — I20.0, I21, I22 Hospital discharge: ICD-9 — 410\|4110 Hospital discharge: ICD-8 — 410\|4110 Cause of death: ICD-10 — I21, I22, I23, I24, I25, I46, R96, R98 Cause of death: ICD-9 — 41[0-4]\|798 Cause of death: ICD-8 — 41[0-4]\|798 Cause of death: excluded ICD-9 — 7980A 2 out of 7 registries used, show all original rules.	46567
4. Check minimum number of events None	46567
5. Include endpoints I9_REVASC I9_MI	58263
6. Filter based on genotype QC (FinnGen only)	58263

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	I9_CHD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_REVASC\|I9_MI
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY	YES
HD_ICD_10_ATC
HD_ICD_10	I200\|I21\|I22
HD_ICD_9	410\|4110
HD_ICD_8	410\|4110
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY	YES
COD_ICD_10	I2[1-5]\|I46\|R96\|R98
COD_ICD_9	41[0-4]\|798
COD_ICD_8	41[0-4]\|798
COD_ICD_10_EXCL
COD_ICD_9_EXCL	7980A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Major coronary heart disease event based on the number of shared cases.

Similar with more cases:

Hard cardiovascular diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	732921	276052	440492
Only index persons	390286	156444	233842
Unadjusted period prevalence (%)
Whole population	10.76	7.91	12.31
Only index persons	7.65	5.75	8.93
Median age at first event (years)
Whole population	69.86	75.87	66.19
Only index persons	69.43	75.36	65.46

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	58263	17471	40792
Unadjusted period prevalence (%)	14.38	5.96	17.98
Median age at first event (years)	66.67	69.29	65.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16738: Matched controls
138294

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

37.9

323.0

3823

1071

AN2

Balloon angioplasty, including several vessels

+∞

323.0

2125

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

37.4

323.0

2155

544

280

Kela drug reimbursment

Clopidogrel

168.1

323.0

532

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2096.0

323.0

991

Coronary artery bypass surgery

+∞

323.0

334

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

109.3

323.0

413

I20.01

ICD-10 Finland

Unstable angina

440.1

323.0

1554

I25.1

ICD-10 Finland

Atherosclerotic heart disease

37.2

323.0

10333

5748

I50.1

ICD-10 Finland

Left ventricular failure

7.3

323.0

946

1129

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.8

323.0

4564

16363

C10AX09

ATC

ezetimibe; oral

7.0

323.0

4631

7134

I20.00

ICD-10 Finland

Unstable angina

278.7

323.0

1552

C10AA01

ATC

simvastatin; oral

3.2

323.0

9430

40140

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

16376.6

323.0

3227

C07AB02

ATC

metoprolol; systemic

2.6

323.0

3736

13665

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

323.0

4935

21437

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

21.3

323.0

1874

813

C10AA07

ATC

rosuvastatin; oral

2.7

323.0

5952

23334

I20.90

ICD-10 Finland

Angina pectoris, unspecified

9.4

323.0

949

878

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

323.0

8687

41220

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.3

323.0

5989

15763

I25.2

ICD-10 Finland

Old myocardial infarction

179.7

323.0

3176

180

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

51.1

323.0

440

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

323.0

4269

17323

C09AA05

ATC

ramipril; oral

4.7

323.0

6764

17452

C10AA05

ATC

atorvastatin; oral

5.0

323.0

10617

35559

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.8

323.0

4761

7621

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2549.0

323.0

3579

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

28.0

323.0

620

190

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

323.0

3206

WX872

NOMESCO Finland

Intensive care

7.7

323.0

1804

2134

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

63.4

323.0

9584

2863

I50.9

ICD-10 Finland

Heart failure, unspecified

5.1

323.0

2270

4164

AN4

Balloon angioplasty and drug eluding stent

+∞

323.0

2194

AA1

Conventional CABG

+∞

323.0

627

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

29.8

323.0

11645

9863

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

323.0

1178

RD211

NOMESCO Finland

4.7

323.0

1291

2432

A10AE04

ATC

insulin glargine; parenteral

3.2

323.0

2026

5640

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

5661.6

323.0

667

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.3

323.0

1917

5208

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

94.2

323.0

1937

192

I20.99

ICD-10 Finland

Angina pectoris, unspecified

9.2

323.0

2005

2015

I50.0

ICD-10 Finland

Congestive heart failure

6.5

323.0

1146

1548

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

12.1

323.0

910

656

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3107.5

323.0

737

Angiography of the heart and coronary arteries

13.0

323.0

1671

1174

AN1

Coronary angiography

21.6

323.0

5803

3308

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3437.0

323.0

1188

I10

ICD-10 Finland

Essential (primary) hypertension

2.4

323.0

10949

60840

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

323.0

3596

11061

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

8.1

323.0

956

1032

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

395.4

323.0

1610

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

43.7

323.0

3308

775

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

11422

72463

C07AB07

ATC

bisoprolol; oral

6.3

323.0

12173

41319

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

323.0

768

C08CA01

ATC

amlodipine; oral

2.2

323.0

6723

32889

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

15.4

323.0

9433

10707

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

5.4

323.0

1679

2803

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.7

323.0

1771

3371

C03CA01

ATC

furosemide; systemic

3.3

323.0

5160

16490

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

323.0

2561

XF402

NOMESCO Finland

ECG with work load test

3.6

323.0

3005

7875

I25

ICD-10 Finland

Chronic ischaemic heart disease

24.1

323.0

1858

711

103

Kela drug reimbursment

Diabetes, insulin-treated

2.4

323.0

5193

21793

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

9811.3

323.0

1118

I20.09

ICD-10 Finland

Unstable angina

184.3

323.0

3773

218

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

13.5

323.0

1547

1034

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

9.3

323.0

1044

978

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

5777.9

323.0

680

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

20.7

323.0

3117

1509

K76

ICPC

Ischaemic heart dis without angina

25.0

323.0

910

317

A10BA02

ATC

metformin; oral

2.1

323.0

4997

23095

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

382

B01AC24

ATC

ticagrelor; oral

541.3

323.0

3155

Single vessel balloon catheter extension

+∞

323.0

679

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.7

323.0

2460

6136

AN3

Balloon angioplasty and metallic stent

+∞

323.0

1378

R07.4

ICD-10 Finland

Chest pain, unspecified

4.3

323.0

7624

22710

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

5.8

323.0

1096

1662

B01AC04

ATC

clopidogrel; oral

14.3

323.0

6567

5962

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

991

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

491

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.9

323.0

5040

11124

B01AA03

ATC

warfarin; systemic

2.6

323.0

2955

10502

C01DA14

ATC

isosorbide mononitrate; oral

15.8

323.0

4826

3460

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.6

323.0

4668

8883

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

323.0

2081

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

25.7

323.0

508

168

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

13.0

323.0

2060

1482

205

Kela drug reimbursment

Chronic hypertension

2.2

323.0

4828

21288

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

323.0

542

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

323.0

580

C03DA01

ATC

spironolactone; oral

3.1

319.3

2039

5946

R06.0

ICD-10 Finland

Dyspnoea

2.1

316.8

4398

19670

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

316.3

2542

8595

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.9

311.4

1451

3304

WX892

NOMESCO Finland

Monitored bed care

3.4

304.4

1682

4403

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

305.2

301.6

328

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

298.1

4915

23513

T90

ICPC

Diabetes non-insulin dependent

2.1

297.0

4316

19590

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

287.9

1415

3364

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

285.9

2101

6691

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.3

285.7

3126

12427

A11

ICPC

Chest pain NOS

3.2

279.7

1669

4613

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.4

278.2

1539

4019

Z50.0

ICD-10 Finland

Cardiac rehabilitation

25.1

276.1

416

140

K84

ICPC

Heart disease other

7.5

272.8

700

797

R07.3

ICD-10 Finland

Other chest pain

2.8

267.9

1983

6327

201

Kela drug reimbursment

Chronic cardiac insufficiency

5.5

261.4

855

1350

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

257.0

265

K74

ICPC

Ischaemic heart dis with angina

18.8

253.7

418

188

N02AX02

ATC

tramadol; systemic, rectal

1.8

252.3

7497

43481

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

2121.1

250.7

261

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.5

250.2

714

947

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.8

249.3

1844

5864

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

4.6

249.1

959

1811

AP1

Catheterization of the left side of the heart

11.9

246.7

489

349

FL1AC

NOMESCO Finland

Left cardioangiography

12.2

243.1

477

333

C10AA04

ATC

fluvastatin; oral

2.9

241.6

1662

5041

R4110

NOMESCO Finland

Physiotherapy

1.9

233.5

4790

24402

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

50.3

231.4

299

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

231.4

2892

12102

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

678.0

229.3

243

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

62.6

226.8

283

I20.91

ICD-10 Finland

Angina pectoris, unspecified

24.5

226.1

343

118

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.4

224.8

1222

3129

SPAT1262

SPAT

Handing over of treatment supplies

2.1

223.2

3215

14274

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

222.3

3591

16691

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

8.3

217.1

520

529

C10AA03

ATC

pravastatin; oral

3.0

216.3

1396

4045

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

37.9

215.0

293

N02BE01

ATC

paracetamol; systemic, rectal

1.9

213.9

14294

103697

207

Kela drug reimbursment

Chronic arrhythmias

2.3

211.7

2182

8298

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

4.7

210.4

787

1438

A10AE05

ATC

insulin detemir; parenteral

3.5

209.7

1114

2798

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.6

206.8

1029

2451

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

237.7

205.1

226

I20.0

ICD-10 Finland

Unstable angina

29.8

204.2

294

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

35.2

200.2

277

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

12.8

199.6

382

252

A10AA02

ATC

4.9

197.1

712

1252

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.3

196.6

2160

8454

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

42.3

196.6

262

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

12.9

196.1

374

245

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

63.4

194.4

242

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

20.0

189.3

305

128

SPAT1097

SPAT

Recording of ECG

2.1

187.5

2610

11333

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

11.2

186.0

379

286

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

1528.8

182.8

191

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.0

181.4

792

1680

AA1AD

NOMESCO Finland

CT of head and brain

1.8

180.2

3754

18909

XF404

NOMESCO Finland

Ambulatory ECG

2.4

174.2

1685

6166

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

18.8

173.5

285

127

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

172.1

4575

24826

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

171.5

177

A10AA01

ATC

4.8

171.4

630

1127

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.9

170.3

767

1672

B01AC22

ATC

prasugrel; oral

67.3

169.4

209

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.3

167.8

1860

7273

FXZ00

NOMESCO Finland

Off-pump cardiac operation

49.3

163.7

212

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

163.3

1467

5155

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

162.4

3085

14981

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.4

158.7

842

2102

C09AA02

ATC

enalapril; systemic

1.8

156.6

3040

14850

I20

ICD-10 Finland

Angina pectoris

8.5

156.6

369

365

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

4.0

155.5

680

1442

A10BK03

ATC

empagliflozin; oral

2.4

153.8

1458

5264

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.5

150.3

587

1117

Z71.8

ICD-10 Finland

Other specified counselling

1.7

147.5

3616

18991

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.1

147.0

900

2494

N02AA05

ATC

oxycodone; systemic

2.0

141.1

2178

9752

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

140.5

1297

4609

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

140.4

145

A10BB12

ATC

glimepiride; oral

2.8

137.8

996

3076

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

137.4

4553

25943

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.4

136.8

1263

4486

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.3

136.6

767

1996

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

135.2

1239

4382

I35.0

ICD-10 Finland

Aortic (valve) stenosis

3.3

134.8

746

1920

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

132.8

1771

7466

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

+∞

132.6

137

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.5

131.9

276

220

H3603, E103

ICD-10 Finland

7.8

131.4

325

348

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

26.6

131.2

194

Catheterization and pressure measurement of the left side of the heart

10.0

131.0

281

235

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

387.3

130.0

140

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

18.3

129.2

214

TK800

NOMESCO Finland

Hemodialysis

4.5

128.0

499

947

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

127.5

2005

9015

A10BH01

ATC

sitagliptin; oral

2.1

127.2

1591

6521

Multi-vessel balloon catheter extension

+∞

126.8

131

AA2

Off pump CABG sternotomy

+∞

126.8

131

ZX120

NOMESCO Finland

Intravenous

2.1

124.0

1568

6454

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

123.9

2533

12480

R53

ICD-10 Finland

Malaise and fatigue

1.8

123.4

2718

13710

C08CA13

ATC

lercanidipine; oral

1.9

123.0

2183

10250

T89

ICPC

Diabetes insulin dependent

3.2

122.8

721

1936

S18

ICPC

Laceration/cut

1.5

122.4

6581

41769

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

362.0

121.4

131

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

121.1

1762

7679

111

Conventional CABG

+∞

120.0

124

ANB

Coronary thrombectomy

+∞

120.0

124

FNG10

NOMESCO Finland

Embolectomy of coronary artery

+∞

119.1

123

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

6.3

119.0

344

462

R02

ICPC

Shortness of breath/dyspnoea

2.0

118.4

1812

8045

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

523.3

118.2

126

N03AX12

ATC

gabapentin; oral

1.8

118.0

2592

13042

C08DB01

ATC

diltiazem; oral

3.1

117.2

712

1958

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

+∞

117.1

121

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

116.3

600

1461

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.1

115.8

495

1026

SPAT1254

SPAT

Administration of medicine

1.9

115.3

1942

8931

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

114.9

1300

5082

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

+∞

113.3

117

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

8.7

112.9

261

250

SPAT1263

SPAT

Sampling

1.5

112.7

6147

38918

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.8

112.5

526

1181

C01AA05

ATC

digoxin; systemic

2.9

112.4

767

2280

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

111.6

5827

36529

ANE

Coronary internal ultrasound (IVUS)

149.8

111.2

126

M04AA01

ATC

allopurinol; systemic

2.0

111.2

1687

7456

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.7

110.4

275

298

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.3

109.6

439

855

R07.2

ICD-10 Finland

Precordial pain

4.1

108.5

465

966

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

108.1

831

2655

I20.10

ICD-10 Finland

Angina angiospastic

21.2

106.7

168

SPAT1252

SPAT

Overall medication plan or its review

2.3

106.3

1051

3847

K01

ICPC

Heart pain

6.5

105.7

295

378

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

38.1

104.8

142

I47.2

ICD-10 Finland

Ventricular tachycardia

4.7

104.7

384

684

N03AX16

ATC

pregabalin; oral

1.6

104.3

3833

22114

B01AF02

ATC

apixaban; oral

2.1

103.9

1347

5581

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.4

103.5

411

794

C09CA01

ATC

losartan; oral

1.6

103.4

3863

22370

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

54.5

103.2

131

C08CA02

ATC

felodipine; oral

2.1

101.2

1331

5545

H02AB06

ATC

prednisolone; systemic

1.4

99.7

7040

46555

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

28.6

99.5

144

I20.9

ICD-10 Finland

Angina pectoris, unspecified

7.7

97.7

243

263

J01FF01

ATC

clindamycin; systemic

1.5

97.6

4274

25607

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

6.7

97.6

266

330

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

96.1

809

2720

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

96.0

5950

38282

I21

ICD-10 Finland

Acute myocardial infarction

94.0

95.7

113

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

95.3

1139

4551

SPAT1301

SPAT

No procedures

1.5

94.8

4423

26834

SPAT1310

SPAT

Counselling related to known health issue

1.5

94.8

4684

28771

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

94.7

1507

6758

C01BD01

ATC

amiodarone; systemic

3.5

94.6

490

1196

R03BB04

ATC

tiotropium bromide; inhalant

2.0

93.9

1366

5919

N18.8

ICD-10 Finland

Other chronic renal failure

3.9

93.2

421

917

SPAT1216

SPAT

Assessment of functional ability

1.7

92.5

2015

10046

WZC30

NOMESCO Finland

Teaching

1.7

92.3

2145

10906

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

91.9

958

3594

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

91.9

4989

31193

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

3.1

90.9

534

1432

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.6

90.8

454

1077

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

90.2

553

1527

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

90.1

2516

13466

I50

ICD-10 Finland

Heart failure

4.4

89.7

348

657

C07AG02

ATC

carvedilol; oral

2.3

89.1

901

3329

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

88.9

938

3538

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

4.2

88.8

365

729

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

88.8

813

2857

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

87.9

4084

24675

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

87.9

1411

6342

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

87.7

1551

7211

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.0

86.9

376

788

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

86.7

7295

49347

R42

ICD-10 Finland

Dizziness and giddiness

1.6

86.5

3013

17046

S97

ICPC

Chronic ulcer skin

2.4

86.4

789

2768

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.3

86.0

474

1213

R55

ICD-10 Finland

Syncope and collapse

1.9

85.1

1405

6375

R03AC02

ATC

salbutamol; inhalant

1.4

84.9

7844

53854

C02AC05

ATC

moxonidine; oral

2.5

84.6

754

2611

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

11.2

84.5

170

126

K75

ICPC

Acute myocardial infarction

55.0

83.8

106

NHQ40

NOMESCO Finland

Amputation of toe

5.0

83.5

291

491

K22

ICPC

Risk factor cardiovascular disease

2.3

83.5

848

3140

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.8

83.2

254

367

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.2

82.6

214

247

A10BB01

ATC

glibenclamide; oral

4.0

82.5

358

753

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.7

82.3

611

1908

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

25.0

82.2

123

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.2

81.9

274

442

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.0

81.7

352

735

M79.6

ICD-10 Finland

Pain in limb

1.4

81.6

5356

34536

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

7.4

81.5

208

235

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.9

81.4

287

491

C03AA03

ATC

hydrochlorothiazide; oral

1.9

81.3

1434

6656

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

80.2

843

3171

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

79.8

1052

4372

EBA00

NOMESCO Finland

Extraction of tooth

1.4

79.7

4768

30181

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

78.9

3389

20053

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.7

78.6

287

510

I21.20

ICD-10 Finland

Acute transmural myocardial infarction with other localization no detected stenosis of coronary artery

688.2

78.4

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

78.3

1149

4981

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

78.1

2539

14079

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

77.9

4138

25575

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

10.4

77.9

163

131

R11

ICD-10 Finland

Nausea and vomiting

2.0

77.8

1054

4429

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

347.1

77.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

77.4

2075

10944

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.4

77.2

304

583

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

71.0

77.1

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.2

76.8

258

418

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

76.4

508

1481

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4.0

76.3

327

680

C09DX04

ATC

valsartan and sacubitril; oral

7.6

76.2

191

210

K92

ICPC

Atherosclerosis/periph vascular dis

5.9

75.5

227

322

M10.9

ICD-10 Finland

Gout, unspecified

2.2

75.5

837

3225

Z00.0

ICD-10 Finland

General medical examination

1.6

75.5

2583

14492

B01AB05

ATC

enoxaparin; parenteral

1.4

75.1

4544

28753

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.2

75.1

308

615

A28

ICPC

Limited function/disability NOS

1.7

74.8

1631

8096

A12BA01

ATC

potassium chloride; oral

2.8

74.7

508

1503

A10BH05

ATC

linagliptin; oral

2.5

74.4

626

2099

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

74.4

1877

9724

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

74.1

6137

41025

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.4

73.9

395

988

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.6

73.5

572

1835

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

7.5

73.2

185

206

H3603, E113

ICD-10 Finland

6.6

73.0

202

257

I21.12

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

638.1

72.7

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.7

72.3

224

330

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

71.9

1087

4762

K02

ICPC

Pressure/tightness of heart

3.2

71.7

413

1092

A46

ICD-10 Finland

Erysipelas

1.6

71.2

1956

10363

R04.0

ICD-10 Finland

Epistaxis

2.0

71.2

945

3934

A11CC03

ATC

alfacalcidol; systemic

3.3

71.1

385

973

I21.02

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

70.6

B01AC07

ATC

dipyridamole; systemic

3.6

70.2

348

821

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.3

69.7

378

956

C09AA04

ATC

perindopril; oral

2.2

69.7

766

2939

C08CA07

ATC

nisoldipine; oral

9.0

69.7

157

145

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

+∞

69.7

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.2

69.7

230

366

SPAT1255

SPAT

Intravenous administration of medicine

2.0

69.6

952

4011

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

69.5

419

1143

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

7.5

69.5

175

194

A10AE06

ATC

insulin degludec; parenteral

2.7

69.4

501

1538

PE1AT

NOMESCO Finland

Femoral artery PTA

6.1

69.4

202

275

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

69.3

905

3740

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.8

69.1

483

1453

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

7.9

68.7

168

178

H3601, E113

ICD-10 Finland

4.5

68.6

263

492

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

68.5

1384

6701

A12AA04

ATC

calcium carbonate; oral

4.1

68.4

286

582

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

68.2

1022

4460

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

68.2

2359

13238

K78

ICPC

Atrial fibrillation/flutter

2.1

67.5

831

3352

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

67.4

2335

13103

K29

ICPC

Cardiovascular sympt/complt other

2.4

67.1

609

2126

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

8.2

67.0

160

163

I20.8

ICD-10 Finland

Other forms of angina pectoris

12.2

66.8

129

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

66.8

2740

15975

C10AX13

ATC

evolocumab; parenteral

20.8

66.6

105

L28

ICPC

Limited function/disability (L)

1.6

66.5

1951

10502

I42.8

ICD-10 Finland

Other cardiomyopathies

8.8

66.5

152

144

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

7.0

66.4

176

211

J01DB01

ATC

cefalexin; oral

1.4

66.3

12807

97066

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

65.9

1821

9652

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.7

65.9

204

301

C08CA05

ATC

nifedipine; systemic

2.1

65.9

781

3100

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

65.6

3112

18696

I51.4

ICD-10 Finland

Myocarditis, unspecified

7.9

65.6

160

169

WX720

NOMESCO Finland

Own respiration

2.4

65.4

622

2226

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.1

65.4

171

201

N05CF01

ATC

zopiclone; oral

1.4

65.3

4616

29868

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

65.0

896

3786

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.1

64.7

379

1014

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.7

64.2

233

412

A02BC01

ATC

omeprazole; systemic

1.4

64.1

3879

24400

SPAT1081

SPAT

Cardiorespiratory global assessment

2.1

63.9

816

3342

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

63.8

1194

5635

A02BC03

ATC

lansoprazole; oral

1.4

63.3

4382

28223

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.7

63.2

193

280

WW502

NOMESCO Finland

Autotransfusion

8.5

63.1

147

144

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

63.1

496

1603

H36.01

ICD-10 Finland

Diabetic maculopathy

4.8

63.1

227

398

UJF32

NOMESCO Finland

Coloscopy

1.4

62.9

3725

23329

C09CA03

ATC

valsartan; oral

1.7

62.9

1360

6718

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

62.8

1498

7615

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

4.1

62.7

261

529

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

62.7

2176

12198

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

119.5

62.6

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

62.3

846

3552

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

62.2

672

2557

R51.80

ICD-10 Finland

Headache

1.6

62.2

1922

10476

PD5AD

NOMESCO Finland

CT of aorta

4.2

62.1

253

503

H04AA01

ATC

glucagon; nasal, parenteral

3.4

62.0

329

819

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.0

62.0

392

1106

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.9

61.6

217

372

C10AA02

ATC

lovastatin; oral

2.6

61.6

475

1517

SPAT1104

SPAT

Monitoring of emergency patient

1.9

61.3

949

4189

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.3

61.1

637

2384

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.3

60.9

610

2240

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.8

60.9

185

267

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

60.8

4216

27119

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

60.7

1096

5107

A02BA02

ATC

ranitidine; systemic

1.5

60.6

2792

16641

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.8

60.5

279

620

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

9.5

60.3

132

116

H3600, E103

ICD-10 Finland

4.6

60.3

225

410

-1

NOMESCO Finland

1.4

59.8

4591

30017

A06AD11

ATC

lactulose; oral

1.6

59.8

1614

8484

M48.0

ICD-10 Finland

Spinal stenosis

1.6

59.7

1700

9065

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

59.5

1715

9171

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.2

59.4

197

316

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

59.2

667

2585

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.8

59.1

211

367

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

59.0

1564

8184

FXG00

NOMESCO Finland

Insertion and use of IABP

36.9

59.0

315

Kela drug reimbursment

Clopidogrel

6.5

58.7

163

209

R50.9

ICD-10 Finland

Fever, unspecified

1.6

58.7

1748

9430

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

58.7

906

3994

C02EA02

ATC

2.6

58.4

452

1446

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

11.0

58.4

118

SPAT1153

SPAT

Removal of sutures

1.4

58.3

4701

30959

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

58.1

2441

14259

N18.0

ICD-10 Finland

End-stage renal disease

4.8

57.9

206

357

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

4.8

57.8

205

354

5315

FHL

Bypass surgery using a mammary artery

+∞

57.1

A04

ICPC

Weakness/tiredness general

1.7

56.9

1424

7326

K77

ICPC

Heart failure

4.6

56.6

212

388

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.7

56.6

424

1332

H3601, E103

ICD-10 Finland

4.8

56.4

200

346

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

56.3

607

2307

G47.3

ICD-10 Finland

Sleep apnoea

1.4

56.3

3446

21638

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.4

56.2

220

421

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

+∞

56.1

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3014007) Fractional oxyhemoglobin in Arterial blood

3844

13101

2.07

323.31

10.9

8.8

93.8

93.9

0.45

3828

13059

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3822

13043

2.07

320.06

10.7

8.7

1.4

1.98

3797

12955

(3002032) Base excess in Venous blood by calculation

5048

19061

1.89

317.17

4.9

3.7

mmol/l

1.8

1.9

1.10

4124

15695

(3009508) Creatinine [Moles/volume] in Urine

13426

66150

1.56

315.95

3.4

3.2

mmol/l

7.2

7.6

20.29

11259

54939

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7777

33556

1.70

312.13

2.0

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19819

106677

1.53

310.09

6.4

6.5

umol/l

12.2

11.8

4.24

18974

101057

(3020682) Albumin/Creatinine [Ratio] in Urine

14006

67983

1.61

307.65

4.3

4.0

mg/mmol

13.7

8.1

22.70

9372

42396

(3022217) INR in Platelet poor plasma by Coagulation assay

6971

28539

1.78

307.65

30.2

25.4

inr

1.5

1.4

7.17

906

3964

(3022948) Iron [Moles/volume] in Serum or Plasma

7796

31336

1.84

307.65

3.2

2.4

umol/l

11.4

13.6

2.99

7255

28851

(3032080) INR in Blood by Coagulation assay

19431

85959

2.10

307.65

12.5

9.0

inr

1.4

1.3

3.15

5424

23663

(3020779) Urea [Moles/volume] in Serum or Plasma

5377

18114

2.15

307.65

9.9

6.9

mmol/l

11.3

10.0

25.51

5110

17182

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

14128

63058

1.81

307.65

2.6

2.1

u/l

238.1

213.1

2.10

13252

58867

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2478

6964

2.47

307.65

3.6

2.8

u/ml

0.3

0.4

1.81

1586

3802

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7323

29057

1.85

307.65

3.2

2.4

g/l

2.3

0.02

6836

26712

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

16488

60835

2.49

307.65

4.0

2.8

ng/l

2144.7

1197.0

68.68

14965

51656

(3023368) Bacteria identified in Blood by Culture

12601

57749

1.70

307.65

5.0

4.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5078

19074

1.90

307.65

4.9

3.7

kpa

5.8

0.62

4924

18557

(3027801) Oxygen [Partial pressure] in Arterial blood

6939

23506

2.20

307.65

8.8

6.9

kpa

11.7

12.3

15.44

6605

22446

(3012544) pH of Venous blood

5373

19706

1.96

307.65

5.0

3.7

7.4

1.13

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4066

12450

2.33

307.65

8.9

6.7

mmol/l

24.5

24.8

4.61

3837

11600

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

18493

77845

2.20

307.65

5.9

3.3

ng/l

165.3

37.5

5.97

14923

56426

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10838

48990

1.68

307.65

2.6

2.2

mg/l

3.2

3.0

11.84

9458

41319

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3844

12987

2.09

307.65

10.9

8.8

0.7

1.37

3818

12910

(3019060) Gas panel - Arterial blood

4293

13339

2.30

307.65

6.0

4.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

23665

119916

1.92

307.65

6.9

4.6

mmol/l

7.2

6.8

113.52

22752

112581

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5835

19320

2.21

307.65

9.7

7.7

g/l

120.2

121.7

6.01

5651

18650

(3016502) Oxygen saturation in Arterial blood

6435

20957

2.28

307.65

9.1

7.3

95.4

95.6

1.65

6198

20234

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6942

23524

2.20

307.65

8.8

6.9

kpa

5.0

5.1

8.79

6609

22473

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8989

30741

2.27

307.65

2.5

2.0

31.0

29.6

50.37

8765

29854

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7000

27280

1.88

307.65

3.3

2.5

20.0

22.9

60.64

5980

23074

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11302

38657

2.38

307.65

6.5

3.2

ng/l

1367.3

206.7

31.93

10357

31009

(3014576) Chloride [Moles/volume] in Serum or Plasma

6715

26471

1.85

307.65

8.7

6.9

mmol/l

104.4

104.3

1.01

6543

25930

(3012516) Albumin [Mass/volume] in Urine

13373

64453

1.61

307.65

3.5

3.2

mg/l

318.7

422.0

2.13

9217

40124

(3003396) Base excess in Arterial blood by calculation

6882

23537

2.17

307.65

8.8

6.9

mmol/l

1.1

0.34

5422

18772

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5672

17233

2.42

307.65

3.8

2.6

ng/l

296.1

175.5

46.64

5285

15685

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

7265

15995

3.54

307.65

3.0

2.1

ug/l

11.3

5.8

36.62

6552

13589

(3018405) Lactate [Moles/volume] in Arterial blood

2382

6897

2.40

294.84

5.0

4.0

mmol/l

1.4

1.12

2342

6783

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7680

33708

1.66

285.30

3.7

3.4

mmol/l

0.8

1.25

7174

31293

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5670

22893

1.77

284.61

1.9

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8984

41115

1.61

282.16

2.2

1.7

mg/l

1.3

1.4

0.74

7057

31957

(3000991) Gas panel - Venous blood

4571

17402

1.86

277.07

10.6

8.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3304

11269

2.05

274.88

12.2

9.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5637

22980

1.75

272.62

1.9

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

4152

15628

1.87

259.49

4.0

3.0

kpa

4.7

4.6

1.85

4007

15140

(3043409) Potassium [Moles/volume] in Arterial blood

2039

5909

2.38

250.81

5.4

4.2

mmol/l

3.9

8.99

1922

5562

(3014111) Lactate [Moles/volume] in Serum or Plasma

4676

18465

1.79

249.98

8.8

6.7

mmol/l

1.4

1.3

3.91

4491

17804

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6270

27037

1.66

244.31

8.1

5.6

mmol/l

1.1

1.0

45.54

5870

25047

(3004119) Hemoglobin [Mass/volume] in Venous blood

3402

12485

1.90

227.87

4.4

3.1

g/l

124.0

129.7

36.66

3306

12230

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2554

8498

2.08

225.00

6.3

4.7

1.7

1.6

2.69

2403

8007

(3020891) Body temperature

2436

8054

2.09

217.96

6.1

4.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2501

8360

2.07

217.43

6.5

4.7

0.9

0.00

2356

7870

(3027945) Reticulocytes/100 erythrocytes in Blood

5562

23963

1.65

214.40

2.5

1.9

1.8

13.00

4970

21037

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

17037

92861

1.42

213.51

4.6

4.0

—

(3004451) EKG impression Narrative

568

828

4.63

206.48

1.4

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18801

105157

1.40

196.39

9.5

6.6

mmol/l

1.2

131.17

16293

87870

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14007

74573

1.41

193.56

3.5

2.7

ug/l

153.8

162.8

2.69

12928

67792

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2148

7258

2.04

180.39

2.9

2.2

ug/l

615.1

546.5

0.30

2067

6824

(3044889) 12 lead EKG panel

24266

143177

1.40

173.08

5.8

3.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

336

347

6.51

172.28

9.5

7.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2951

11313

1.81

169.95

11.5

8.8

mmol/l

24.2

24.4

2.49

2708

10574

(3027273) Bicarbonate [Moles/volume] in Venous blood

2692

10042

1.85

169.18

4.3

3.3

mmol/l

25.1

25.3

1.81

2614

9762

(3047181) Lactate [Moles/volume] in Blood

1873

6247

2.05

162.45

7.9

5.5

mmol/l

1.4

1.3

2.31

1677

5529

(3023520) Reticulocytes [#/volume] in Blood

4227

18174

1.62

160.14

2.5

2.6

e9/l

72.2

68.5

7.76

3266

13759

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2575

9637

1.84

159.83

1.6

1.7

g/l

1.6

2.34

2226

8180

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2573

9651

1.84

158.53

5.4

4.0

mmol/l

23.9

24.2

4.23

2268

8682

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12095

64386

1.38

157.44

2.9

2.6

u/l

57.7

59.4

1.85

11305

58915

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2955

11588

1.76

157.21

1.6

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17042

95893

1.35

155.29

8.7

5.9

mmol/l

1.2

141.34

15756

86088

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2477

9311

1.83

151.31

5.0

3.8

48.6

47.9

0.55

2450

9213

(3039000) Anion gap in Blood

1439

4450

2.20

150.98

8.7

6.3

mmol/l

11.5

11.1

3.33

1307

4034

(3018572) Chloride [Moles/volume] in Blood

1439

4450

2.20

150.98

8.7

6.3

mmol/l

105.2

104.9

0.88

1308

4034

(3038071) Oxygen [Partial pressure] in Mixed venous blood

294

309

6.39

148.48

9.2

7.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2546

9728

1.80

147.38

3.3

2.7

1.3

1.2

0.56

2533

9682

(3024561) Albumin [Mass/volume] in Serum or Plasma

16253

91267

1.34

146.85

5.7

4.8

g/l

34.2

35.2

73.00

15182

84267

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5383

24962

1.52

145.66

4.1

4.4

u/l

254.0

243.4

3.66

5081

23554

(3026008) Bacteria identified in Urine by Culture

11502

61394

1.37

143.76

3.7

3.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3078

12571

1.69

141.03

9.6

6.8

mmol/l

24.5

24.9

5.27

3049

12451

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2476

9528

1.79

139.72

3.3

2.7

0.7

0.59

2383

9136

(3006576) Bicarbonate [Moles/volume] in Blood

386

587

4.42

133.62

8.5

5.1

mmol/l

25.4

25.0

0.81

344

547

(3007853) Bacteria identified in Skin by Aerobe culture

5028

23462

1.50

130.65

2.1

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2266

8659

1.80

130.59

2.1

2.0

ug/l

2.0

2.2

0.46

2022

7599

(3024928) Oxygen saturation in Venous blood

1321

4198

2.14

129.34

4.2

3.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

238

232

6.88

128.23

7.8

6.5

—

(3000850) Epithelial cells [#/volume] in Urine

8498

43927

1.38

125.99

3.1

2.6

e6/l

4.8

4.9

0.47

7563

38248

(3019309) Folate [Moles/volume] in Red Blood Cells

7931

40652

1.39

123.28

1.9

1.8

nmol/l

1200.5

1153.8

4.07

6183

30068

(3000963) Hemoglobin [Mass/volume] in Blood

31051

216815

0.68

120.18

34.6

22.2

g/l

132.3

136.0

279.66

30669

213248

(3026361) Erythrocytes [#/volume] in Blood

31048

216774

0.68

119.51

34.3

22.1

e12/l

4.4

4.5

212.30

30250

209519

(3024731) MCV [Entitic volume]

31048

216766

0.68

119.28

34.2

22.0

91.7

91.4

20.21

30661

213181

(3010813) Leukocytes [#/volume] in Blood

31053

216794

0.68

119.27

34.4

22.1

e9/l

7.3

6.7

236.99

30259

209574

(3035941) MCH [Entitic mass]

31045

216734

0.68

118.87

34.2

22.0

30.4

3.32

30659

213157

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11487

62657

1.33

118.26

3.3

u/l

38.9

35.0

2.44

10883

59054

(3007461) Platelets [#/volume] in Blood

31046

216655

0.68

116.52

34.4

22.1

e9/l

237.8

245.8

79.64

30370

210200

(3026493) Urate [Moles/volume] in Serum or Plasma

10329

55619

1.33

115.56

3.2

2.7

umol/l

4396.9

5173.6

1.05

8900

47718

(3030467) Casts [#/volume] in Urine by Automated count

10727

58464

1.32

108.75

3.7

3.2

e6/l

0.5

0.4

1.77

8511

43749

(3002582) Erythrocytes [#/volume] in Urine

11550

63615

1.31

108.48

3.9

3.3

e6/l

89.3

93.4

0.12

9276

48613

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1451

5094

1.94

108.31

2.5

2.3

ug/min

143.7

104.3

2.30

895

2932

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3396

15169

1.54

106.55

1.7

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

9751

52573

1.32

106.11

5.0

4.0

83.4

88.7

74.17

9528

51334

(3042936) Bacteria identified in Isolate by Culture

5917

29584

1.40

104.06

2.5

2.0

—

(21494755) Public health laboratory ask at order entry panel

1032

13455

0.50

103.74

1.4

—

(3026782) Osmolality of Urine

7835

41185

1.34

100.31

3.3

2.8

mosm/kgh2o

534.5

554.4

12.90

6811

34892

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

25669

157531

1.30

99.67

8.7

7.8

u/l

82.0

79.3

12.36

24435

147665

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3028

13427

1.55

97.70

4.5

3.6

kpa

5.1

5.2

2.53

2810

12326

(3028626) Oxygen [Partial pressure] in Capillary blood

1281

4474

1.94

96.94

3.5

3.0

kpa

7.9

8.0

1.09

1197

4130

(3009343) pH of Capillary blood

2989

13260

1.55

96.17

4.5

3.5

7.4

0.91

425

1766

(36304419) Bacteria [Presence] in Urine

10260

56320

1.30

95.81

3.7

3.2

—

(3044640) Blood type and Crossmatch panel - Blood

11511

64180

1.29

95.28

2.9

2.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2880

12800

1.54

91.70

4.4

3.5

mmol/l

1.8

0.15

2101

9639

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1451

5405

1.82

90.14

3.1

2.5

g/l

3.6

3.7

0.49

1391

5169

(3006315) Basophils [#/volume] in Blood

16816

98657

1.26

89.54

6.2

5.9

e9/l

0.0

3.62

14580

84240

(3001604) Monocytes [#/volume] in Blood

16720

98112

1.25

88.44

6.2

5.9

e9/l

0.6

68.58

14471

83741

(3018095) Leukocytes [#/volume] in Urine

12803

72831

1.27

88.21

4.4

3.8

e6/l

108.4

105.0

0.14

9805

52082

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1551

5993

1.76

85.26

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1201

14112

0.55

85.08

2.1

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

17057

100600

1.25

84.77

6.3

6.0

e9/l

1.9

1.93

15027

87335

(3013115) Eosinophils [#/volume] in Blood

17218

101687

1.25

84.38

6.4

6.1

e9/l

0.2

14.85

15168

87961

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1209

4338

1.89

84.36

3.1

nmol/l

0.8

1.28

918

3368

(3021589) Normoblasts [#/volume] in Blood

14968

87025

1.25

84.26

12.3

10.0

e9/l

0.0

0.12

12511

71178

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1393

5256

1.80

82.91

3.6

3.0

mmol/l

24.6

24.9

1.85

1224

4611

(3018418) pH of Serum or Plasma

11135

62683

1.27

82.05

5.2

4.2

7.4

1.57

2294

11825

(3021901) Oxygen saturation in Capillary blood

1090

3815

1.93

81.87

3.2

2.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

19052

114152

1.24

79.98

8.7

9.5

e9/l

4.6

4.1

90.99

16705

98917

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8955

49282

1.28

78.57

2.8

2.4

—

(3010421) pH of Blood

1410

5468

1.75

76.43

5.4

3.8

7.4

2.33

1194

4698

(40767503) Oxygen content in Capillary blood by calculation

1208

4529

1.81

73.33

2.9

2.5

15.9

16.4

3.14

626

2391

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

851

2845

2.02

72.71

7.3

6.0

mg/l

11.9

11.7

0.49

776

2606

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8080

44257

1.28

72.51

1.8

1.7

pmol/l

33611875.2

32513509.6

0.06

6712

35761

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2775

12843

1.48

72.17

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

8941

49646

1.27

71.62

1.7

1.5

nmol/l

19.2

20.6

13.62

7828

41784

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

14877

87481

1.23

70.93

2.2

2.0

pmol/l

92.9

95.2

6.65

8039

45109

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2109

20661

0.66

69.02

1.3

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

21541

131800

1.22

68.41

5.6

4.6

e6/l

1500.3

1419.4

0.07

352

1952

(3022096) Basophils/100 leukocytes in Blood

15204

89830

1.22

68.25

6.5

6.2

0.6

0.7

8.70

14283

83329

(3036489) Thrombin time

1673

7000

1.62

68.23

2.6

2.0

22.6

21.6

3.91

1528

6151

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

697

9018

0.51

67.53

1.6

1.5

—

(3045716) Anion gap in Serum or Plasma

363

856

2.85

66.73

2.4

mmol/l

9.2

9.1

0.23

288

611

(3006504) Eosinophils/100 leukocytes in Blood

15572

92387

1.22

66.39

6.5

6.2

2.9

0.85

14620

85652

(3019069) Monocytes/100 leukocytes in Blood

15632

92908

1.22

64.90

6.8

6.5

9.0

8.8

6.18

14711

86457

(3020630) Protein [Mass/volume] in Serum or Plasma

3704

18428

1.38

64.24

2.4

2.7

g/l

65.6

66.4

7.93

3374

16631

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1277

5074

1.70

63.39

3.1

2.4

214.6

197.8

8.12

1227

4789

(40768804) Tissue Pathology biopsy report

10663

81939

0.81

63.14

2.1

2.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1380

5618

1.66

62.58

3.1

2.1

86.6

90.2

6.47

1313

5229

(1616796) Gas panel - Central venous blood

1198

4693

1.73

62.58

4.7

3.6

—

(3027315) Oxygen [Partial pressure] in Blood

1228

4844

1.72

62.58

5.4

3.9

kpa

8.5

0.28

1200

4728

(3012501) Base excess in Blood by calculation

1220

4811

1.72

62.23

5.4

3.9

mmol/l

2.4

2.6

1.53

844

3348

(3013290) Carbon dioxide [Partial pressure] in Blood

1220

4813

1.71

62.14

5.4

3.9

kpa

5.0

0.87

1192

4698

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3228

15803

1.40

61.49

5.2

3.7

ng/l

122.1

89.0

40.19

2794

13392

(40761535) Cells panel - Urine sediment

3474

17265

1.38

60.42

4.1

3.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

767

2644

1.96

60.17

2.0

1.8

89.2

89.5

0.39

755

2606

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3321

16395

1.39

60.13

3.2

2.7

ml/min/173m2

56.6

63.9

21.93

1476

6446

(3018010) Neutrophils/100 leukocytes in Blood

15633

93426

1.20

59.18

6.5

6.1

59.4

57.6

60.41

14676

86827

(3028271) Lactate [Moles/volume] in Capillary blood

912

3351

1.84

59.03

2.1

1.8

mmol/l

1.7

0.03

892

3271

(3044242) Glucose [Moles/volume] in Arterial blood

363

918

2.65

58.71

1.8

2.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

15839

94891

1.20

57.91

6.7

6.3

25.1

27.2

93.94

14816

87793

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4433

23034

1.32

57.40

2.7

2.8

umol/l

9.0

9.6

1.08

3917

20191

(3017181) Myelocytes/100 leukocytes in Blood

3457

17359

1.36

56.14

4.2

4.1

0.9

1.0

1.39

997

5242

(3023183) Ammonium ion [Moles/volume] in Plasma

1128

4490

1.70

55.59

2.4

2.8

umol/l

31.9

34.7

3.38

940

3788

(3002179) Metamyelocytes/100 leukocytes in Blood

3157

15683

1.38

54.76

4.1

3.9

0.6

0.7

0.79

733

3778

(3029937) Albumin [Presence] in Urine by Test strip

9210

52580

1.23

54.35

5.1

4.2

estimate

0.0

0.08

3210

16897

(3017569) Oxygen content in Arterial blood

353

921

2.57

53.76

1.9

2.2

—

(3025159) Blasts/100 leukocytes in Blood

3094

15392

1.37

53.11

4.3

4.1

0.2

0.3

0.35

788

4095

(3008037) Lactate [Moles/volume] in Venous blood

1172

4774

1.66

52.97

4.2

3.1

mmol/l

1.6

0.75

1145

4678

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30495

210421

0.78

52.81

13.8

10.9

u/l

28.4

26.4

13.91

29568

202069

(3022313) Gas panel - Capillary blood

2075

9696

1.45

50.79

4.7

3.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

3263

16480

1.35

50.77

4.2

4.1

0.1

1.69

918

4865

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1089

4404

1.67

50.58

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1089

4406

1.67

50.50

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1177

4919

1.62

48.07

1.5

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1140

4738

1.62

47.61

1.5

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1920

9008

1.45

45.90

1.5

u/ml

14.0

16.6

0.26

240

(3035350) Ketones [Presence] in Urine by Test strip

15966

96941

1.18

45.62

4.5

3.7

estimate

0.0

1.47

3432

17355

(4094501)

1323

5759

1.55

45.47

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

24870

174574

0.84

45.44

25.6

16.2

38.4

39.7

60.63

15529

118062

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30617

210670

0.80

45.21

28.3

17.6

umol/l

89.7

79.6

209.68

30611

210587

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1156

4889

1.60

44.96

2.5

2.2

g/l

127.3

130.0

2.64

907

3443

(3003434) Protein [Mass/volume] in Pleural fluid

777

2980

1.76

43.71

1.6

1.5

g/l

29.8

33.7

12.24

679

2691

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1417

6319

1.52

43.61

2.0

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

803

3116

1.74

43.37

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

297

800

2.49

42.52

11.5

3.8

mg/l

724.3

2188.6

0.87

230

551

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6545

36855

1.23

42.31

3.1

2.8

e6/l

1.2

0.17

4031

20964

(3009261) Glucose [Presence] in Urine by Test strip

16121

98365

1.17

41.87

4.6

3.8

estimate

0.0

0.11

3247

17247

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

895

3623

1.66

41.43

1.4

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4056

21692

1.28

41.23

4.4

3.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1582

7308

1.46

40.94

2.8

3.5

mg/l

42.7

46.4

0.46

1290

5934

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3576

18836

1.30

40.92

2.8

2.5

u/l

57.1

46.6

0.22

3044

16116

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1543

7099

1.47

40.77

2.8

3.5

ratio

3.9

5.0

0.25

145

508

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

724

2781

1.75

40.54

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1580

7317

1.46

40.36

2.8

3.5

mg/l

97.3

65.0

0.42

1288

5936

(40760888) Immunoglobulin light chains.free panel - Serum

1235

5440

1.53

40.22

2.8

3.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

15919

97246

1.16

40.00

5.9

5.0

estimate

0.0

1.84

3453

17690

(3004588) Protein electrophoresis panel - Serum or Plasma

2994

15454

1.32

39.71

2.2

2.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

508

1756

1.94

39.67

1.2

1.3

nmol/l

1.6

1.4

3.03

459

1587

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

722

2790

1.74

39.60

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

1066

4569

1.57

39.18

4.4

3.1

mmol/l

8.0

7.6

4.75

1045

4486

(3040151) Glucose [Moles/volume] in Capillary blood

619

2300

1.81

38.75

10.1

8.8

mmol/l

7.7

7.4

1.37

513

1886

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3334

17521

1.30

38.70

5.0

3.9

mmol/l

1.2

12.90

3041

15126

(3013512) EKG study

10683

63454

1.17

37.66

6.0

3.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3762

20144

1.27

37.64

2.1

2.3

g/l

0.2

6.62

3460

18673

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1153

5081

1.53

37.48

1.5

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

688

2666

1.74

37.39

1.5

e6/l

2631.1

3521.3

0.51

508

1933

(3019150) Specific gravity of Urine by Refractometry

7338

42215

1.20

37.39

5.1

4.2

kg/l

1.0

0.76

1224

6383

(3017817) Protein [Mass] in Urine collected for unspecified duration

523

1865

1.88

37.28

2.1

2.5

0.2

0.5

—

(1761868) Lipid panel - Serum or Plasma

8651

65349

0.85

36.31

3.9

3.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3224

17012

1.29

36.16

2.1

2.4

nmol/l

371.9

373.1

0.10

2957

15607

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12297

74090

1.16

35.60

4.9

4.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

21943

138006

1.15

34.77

5.2

4.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1479

6964

1.43

34.57

1.7

1.6

titre

222.0

261.8

0.31

287

(3041354) Potassium [Moles/volume] in Venous blood

688

2726

1.70

34.56

2.9

2.3

mmol/l

4.1

3.82

680

2707

(3035285) Chloride [Moles/volume] in Venous blood

688

2726

1.70

34.56

2.9

2.3

mmol/l

105.6

105.5

0.33

680

2707

(3052851) Hemolysis interference index of Serum or Plasma

1358

6298

1.46

34.40

4.4

3.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

562

6316

0.59

33.09

1.7

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

776

3212

1.62

33.00

1.4

1.5

—

(44806118)

564

2157

1.76

32.15

1.4

1.6

—

(44790048)

564

2158

1.75

32.10

1.4

1.6

—

(44790049)

564

2158

1.75

32.10

1.4

1.6

—

(44790047)

564

2158

1.75

32.10

1.4

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

530

1998

1.78

31.72

1.4

mmol/l

7.1

6.2

9.10

490

1843

(3033705) Calcium.ionized [Moles/volume] in Venous blood

669

2696

1.67

31.59

3.0

2.3

—

(3045788) Cell count panel - Pleural fluid

534

2026

1.77

31.29

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

929

4070

1.54

31.04

1.3

1.2

titre

92.5

139.1

0.66

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5983

34285

1.20

31.01

3.4

3.0

e6/l

2.2

2.4

0.53

3540

18497

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1782

8824

1.36

31.01

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3498

18984

1.25

30.90

1.5

—

(3019977) pH of Arterial blood

345

1144

2.02

30.40

2.3

2.5

7.4

1.48

112

439

(3028308) Erythrocytes [#/volume] in Pleural fluid

612

2435

1.69

30.33

1.5

e6/l

50482.7

59719.6

0.31

380

1446

(3042733) HLA Ab [Presence] in Serum

228

639

2.39

30.19

5.1

4.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1653

8122

1.37

30.18

1.9

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

847

3662

1.56

30.04

1.5

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

270

819

2.21

29.87

37.1

34.3

ug/l

7.4

7.3

0.34

245

734

(42870588) Differential panel, method unspecified - Blood

11537

69846

1.15

29.72

6.2

6.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

7972

46982

1.17

29.44

4.3

3.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

28877

186144

1.17

29.43

8.3

6.0

mmol/mol

43.4

40.1

307.65

27203

169987

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

341

4249

0.53

29.17

1.3

—

(40758558) Short blood count panel - Blood

8507

50487

1.16

28.53

6.8

7.2

—

(3023419) Bacteria identified in Sputum by Culture

656

2714

1.62

28.02

2.1

2.4

—

(3015736) pH of Urine

12435

75913

1.14

27.83

4.2

3.5

6.0

5.7

—

(3012441) Differential panel - Pleural fluid

579

2327

1.67

27.68

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

811

3538

1.54

27.66

5.0

3.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1564

7750

1.36

27.07

2.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

6945

40725

1.17

26.94

5.1

4.7

—

(3004775) Volume in Urine collected for unspecified duration

460

1752

1.76

26.69

2.4

2.2

689.0

688.9

0.00

321

1151

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

691

2939

1.58

26.36

1.4

1.5

—

(3051651) Icteric interference index of Serum or Plasma

340

1183

1.93

26.25

5.3

3.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1687

8501

1.34

26.17

5.1

3.8

mmol/l

24.7

24.9

2.93

1555

7797

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

666

2815

1.59

26.09

2.0

2.2

32.3

32.8

1.93

658

2792

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

302

1010

2.00

26.09

2.3

2.1

ug/min

231.5

77.9

1.08

224

(3039443) Prostate specific Ag panel - Serum or Plasma

472

5184

0.60

25.39

1.6

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

916

8734

0.69

25.13

3.4

3.9

u/ml

98.4

67.0

0.77

888

8392

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

27389

188582

0.87

25.04

21.9

14.2

ml/min/173m2

73.3

77.6

180.30

23725

155770

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

510

2058

1.66

24.08

1.4

1.3

u/l

303.3

511.1

3.87

479

1952

(3017143) Hepatitis C virus Ab [Presence] in Serum

3141

17302

1.23

23.94

1.8

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

499

2014

1.66

23.56

3.2

2.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

561

2335

1.61

23.47

1.6

—

(3025941) Bacteria identified in Stool by Culture

1926

10080

1.29

22.73

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

423

1667

1.70

21.87

1.6

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

166

469

2.37

21.77

4.3

6.9

71.9

70.1

0.36

138

370

(3016750) Collection duration of Urine

339

1258

1.80

21.56

2.2

2.1

min

500.2

498.2

0.13

252

899

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1163

10372

0.74

21.17

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2640

14493

1.23

20.69

2.7

2.8

g/l

10.5

10.6

0.52

2452

13193

(3020876) Protein [Mass/time] in 24 hour Urine

454

1851

1.64

20.69

1.9

2.0

g/24h

1.7

0.8

0.71

(3037756) Immunofixation for Serum or Plasma

1012

4908

1.39

20.06

1.4

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1576

8168

1.30

20.03

2.1

2.4

g/l

10.0

10.3

1.33

1310

6769

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

901

4298

1.41

19.68

1.5

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1088

5358

1.37

19.63

3.7

3.0

mg/l

2.0

1.6

31.41

984

4863

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1007

4908

1.38

19.38

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3215

18113

1.20

19.37

1.8

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

747

3454

1.45

19.35

1.3

u/l

30.4

37.2

1.19

661

2983

(21494890) Protein electrophoresis panel - 24 hour Urine

549

2382

1.55

19.34

1.8

2.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1118

5545

1.36

19.29

1.6

1.5

g/l

1.2

0.56

1063

5263

(40768797) Stomach Pathology biopsy report

4865

28412

1.16

19.14

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1660

8721

1.28

19.01

2.1

2.4

g/l

3.8

3.9

0.33

1200

6159

(3003181) Sodium [Moles/volume] in Urine

823

3892

1.42

18.89

1.4

1.3

mmol/l

61.9

62.0

0.02

660

3088

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1663

8749

1.28

18.83

2.1

2.4

g/l

7.7

7.4

8.55

1219

6469

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1084

5371

1.36

18.83

1.6

1.5

g/l

0.2

1.43

1027

5076

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

590

5782

0.68

18.82

2.1

1.7

mg/l

4.5

3.6

0.89

464

4158

(3000330) Specific gravity of Urine by Test strip

1984

10666

1.25

18.77

4.2

3.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

629

2829

1.49

18.76

1.4

1.3

nmol/l

0.2

0.3

0.19

219

(3028026) IgM [Mass/volume] in Serum or Plasma

2089

11306

1.25

18.63

1.8

2.0

g/l

1.2

1.4

2.86

1899

10200

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1659

8741

1.28

18.57

2.1

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4632

27011

1.16

18.54

11.3

6.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1160

5830

1.34

18.36

1.7

1.4

iu/ml

12.9

14.1

0.15

132

(3035880) pH of Pleural fluid

317

1213

1.75

18.29

1.3

—

(40768806) Pleura Pathology biopsy report

541

2371

1.53

18.24

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

298

1121

1.78

18.22

2.0

2.2

umol/l

37.0

27.1

0.37

(3002256) Pathology report gross observation

3530

27351

0.85

18.22

1.3

—

(3022621) pH of Urine by Test strip

2390

13160

1.23

18.16

3.4

3.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

624

2832

1.48

17.82

1.4

1.3

nmol/l

2.3

1.6

0.16

598

2716

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

859

4137

1.39

17.79

6.3

5.7

iu/ml

2127.8

2049.5

0.02

152

655

(3051611) Lipemic interference index of Serum or Plasma

512

2234

1.54

17.64

4.9

3.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

294

1114

1.77

17.56

1.8

1.9

—

(40768793) Breast Pathology biopsy report

381

4023

0.63

17.45

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

690

3209

1.44

17.39

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

249

900

1.85

17.34

25.2

30.0

ug/l

108.9

114.4

0.62

187

769

(4035726)

2486

19763

0.83

17.11

1.4

—

(3017704) Immunofixation for Urine

311

1211

1.72

16.92

1.3

1.7

—

(3011985) Renin [Units/volume] in Plasma

589

2679

1.47

16.67

1.3

1.4

mu/l

98.0

60.7

1.87

530

2366

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

688

3226

1.43

16.61

1.6

1.4

u/ml

126.6

112.7

0.86

163

719

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

30026

195858

1.13

16.23

23.5

15.0

mg/l

26.3

25.5

3.20

26325

156545

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1542

8189

1.27

16.20

2.2

2.4

g/l

3.2

3.1

2.68

1208

6301

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

571

2601

1.47

16.06

1.4

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

752

3612

1.40

15.87

1.6

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

255

960

1.78

15.63

2.1

2.2

93.1

97.7

1.15

246

907

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

335

1362

1.65

15.58

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

846

4157

1.37

15.57

2.0

1.6

nmol/l

0.9

0.8

3.52

682

3471

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

180

608

1.98

15.37

2.6

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

180

608

1.98

15.37

2.6

2.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

900

4479

1.35

15.27

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

287

3134

0.61

15.26

3.3

3.5

u/ml

35.4

42.2

0.55

268

3040

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

215

777

1.85

15.06

1.5

1.4

64.8

63.0

0.33

170

640

(3014891) Appearance of Pleural fluid

100

266

2.51

15.06

1.6

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

321

1306

1.65

14.91

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2070

11461

1.22

14.88

2.5

2.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

536

2454

1.46

14.74

1.4

1.3

nmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3575

27235

0.86

14.64

5.8

4.7

33.5

32.1

11.90

2828

17650

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1289

6782

1.28

14.64

2.1

2.3

g/l

36.6

37.6

6.41

1106

5758

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

739

3592

1.38

14.57

1.6

1.4

u/ml

18.3

15.8

0.22

(43055442) Apixaban [Mass/volume] in Serum or Plasma

106

295

2.40

14.55

1.6

1.5

ug/l

130.1

108.2

1.09

231

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1232

6455

1.28

14.47

2.2

2.4

g/l

0.0

0.49

1119

5877

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13643

85963

1.09

13.90

4.7

5.0

ug/l

2.7

3.3

2.74

12153

77518

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

487

2218

1.47

13.79

1.2

u/l

53.6

62.5

2.51

344

1467

(3051593) INR in Capillary blood by Coagulation assay

276

1104

1.67

13.73

12.0

10.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

540

2513

1.44

13.68

1.3

pmol/l

242.6

289.5

1.87

405

1930

(40761511) CBC panel - Blood by Automated count

29818

202683

0.89

13.65

22.8

14.0

—

(3034770) Mitochondria Ab [Titer] in Serum

991

5090

1.31

13.57

1.2

titre

799.0

909.1

0.28

144

(3016038) Potassium [Moles/volume] in Urine

328

1377

1.59

13.49

1.2

mmol/l

34.5

34.6

0.03

279

1166

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1915

10631

1.21

13.41

3.1

3.3

pmol/l

4.3

4.4

5.61

1694

9356

(3007566) Smooth muscle Ab [Titer] in Serum

995

5124

1.30

13.36

1.2

titre

125.5

135.1

0.13

420

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

651

3149

1.39

13.27

2.7

u/ml

979.9

6233.6

1.02

193

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8765

54195

1.10

13.13

1.8

1.6

mmol/l

1.4

3.75

7388

44688

(3041096) Erythrocytes [Presence] in Urine by Automated

8226

50709

1.11

13.08

4.3

3.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1145

6039

1.27

12.79

2.2

2.4

g/l

0.0

0.27

1036

5478

(3037121) Protein [Mass/volume] in Urine

1359

7323

1.25

12.66

3.1

3.2

g/l

0.4

0.3

2.47

606

3216

(3014765) Yersinia sp identified in Stool by Organism specific culture

1035

5402

1.29

12.58

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1376

7433

1.24

12.54

2.3

2.6

g/l

0.8

1.0

1.54

1183

6289

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1126

5944

1.27

12.50

2.2

2.4

g/l

0.0

0.00

1028

5463

(42529406) Shigella sp [Presence] in Stool by Culture

1036

5415

1.28

12.45

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

147

1811

0.54

12.41

1.3

pmol/l

66.7

94.5

0.87

602

(1617658) Protocol used for examination of sentinel lymph nodes

106

1445

0.49

12.34

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

123

393

2.09

12.30

1.2

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

451

2072

1.46

12.28

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

379

1682

1.51

12.25

1.3

u/l

13.0

13.9

0.22

338

1567

(3003338) MCHC [Mass/volume]

23458

161064

0.92

12.18

31.3

19.5

g/l

331.3

332.5

75.34

23213

159930

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1023

5356

1.28

12.15

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.96

11.96

19.3

13.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

297

3039

0.65

11.94

1.4

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

359

3532

0.67

11.87

1.5

1.4

pmol/l

210.1

182.9

0.33

352

3441

(40768800) Prostate Pathology biopsy report

640

5710

0.74

11.80

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

121

391

2.07

11.78

1.5

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

353

0.17

11.66

1.9

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

870

4488

1.30

11.60

2.6

2.2

—

(3037522) Nuclear Ab [Titer] in Serum

4140

24709

1.13

11.54

1.4

1.3

titre

525.9

532.2

0.08

932

5166

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

180

673

1.79

11.45

2.3

2.1

168.3

166.4

0.10

168

627

(3024932) HLA-DR beta [Type]

174

645

1.80

11.39

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

264

1101

1.60

11.26

1.3

1.4

nmol/l

1.3

1.2

0.52

206

841

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

309

1340

1.54

11.16

1.2

mmol/l

11.9

12.3

0.36

128

442

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

231

2.37

11.08

1.3

1.2

nmol/l

8.6

237643.1

1.29

186

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

29459

199977

0.90

11.06

7.0

5.1

mmol/l

2.1

2.8

307.65

27690

181552

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

284

1211

1.57

11.05

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

283

1206

1.57

11.04

1.6

1.5

—

(3049717) Cytology report of Urine Cyto stain

1651

9213

1.20

10.99

2.8

2.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

470

2227

1.41

10.90

1.4

1.7

—

(3005033) Fetal Nuchal fold Thickness US

338

0.18

10.87

1.9

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

339

0.18

10.86

1.9

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.20

10.76

4.5

3.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

22838

147876

1.08

10.76

4.7

4.2

mm/h

15.6

13.0

93.16

21259

135573

(3024471) HLA-A [Type]

175

663

1.76

10.69

1.0

—

(40768446) Kidney Pathology biopsy report

198

779

1.70

10.60

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

402

1863

1.44

10.54

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

402

1863

1.44

10.54

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

402

1863

1.44

10.54

1.4

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

14841

103452

0.93

10.51

2.5

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

611

3042

1.35

10.50

1.3

1.2

u/ml

309.2

285.2

0.92

395

1928

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

995

5300

1.26

10.32

1.8

2.0

mg/l

12.0

11.4

0.60

926

4886

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

356

1619

1.47

10.30

1.4

u/l

14.5

12.6

4.63

340

1558

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

306

3014

0.67

10.25

1.6

1.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

199

2.42

10.18

1.3

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

118

402

1.96

10.03

2.7

2.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.34

10.00

13.8

9.0

e6/l

144.8

334.8

0.74

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

413

0.16

9.96

1.9

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

413

0.16

9.96

1.9

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

413

0.16

9.96

1.9

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

254

1083

1.57

9.94

3.6

3.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

412

0.16

9.93

1.9

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

858

4513

1.27

9.90

1.3

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

969

0.45

9.85

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

444

0.19

9.83

1.8

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1508

11932

0.84

9.82

1.3

au/ml

50.9

53.7

0.14

528

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

228

952

1.60

9.75

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

118

407

1.94

9.70

1.3

1.2

mmol/l

1.3

1.7

2.99

245

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1680

13156

0.84

9.70

2.4

au/ml

28.3

28.5

0.01

589

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1981

11387

1.17

9.40

3.3

2.8

e6/l

0.3

0.47

1946

11144

(46235355) HIV 1 and 2 tests - Meaningful Use set

3496

20919

1.13

9.29

1.8

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

171

672

1.70

9.27

1.5

1.4

3.1

2.5

0.38

139

566

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.19

9.16

10.8

9.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

521

2590

1.35

9.11

1.3

1.2

u/ml

5.1

3.7

1.16

241

1156

(3000919) Neutrophils/100 leukocytes in Pleural fluid

155

596

1.74

9.08

1.4

20.9

20.5

0.07

135

545

(3012565) Volume of 24 hour Urine

242

1044

1.55

9.05

2.4

2.2

1804.7

1942.7

1.17

209

915

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

432

2089

1.38

9.00

1.4

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

209

874

1.60

8.93

2.5

2.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

277

2.10

8.92

1.3

u/l

40.4

326.3

1.03

198

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2347

17796

0.87

8.86

2.2

nmol/l

12.2

13.0

5.21

2043

15791

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

636

3273

1.30

8.76

1.3

1.2

—

(3025315) Body weight

172

2.41

8.76

5.9

4.6

—

(3000492) Spirometry study

2996

17824

1.13

8.74

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

244

2428

0.67

8.70

1.6

1.8

—

(3042631) Mycobacterium sp identified in Specimen

620

3183

1.30

8.69

2.7

2.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

326

1.99

8.64

1.5

1.4

10.1

10.7

0.11

167

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.50

8.62

6.7

5.5

umol/l

461.6

417.6

0.52

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

274

1233

1.49

8.46

1.2

u/l

29.1

25.9

0.42

238

1040

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

4.17

8.45

9.4

9.7

33.7

49.4

1.68

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

331

1547

1.43

8.41

1.2

titre

154.7

148.9

0.05

253

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3140

23283

0.89

8.31

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

160

2.42

8.31

1.4

2.1

mmol/l

0.7

1.1

0.93

105

(3044927) Protein electrophoresis panel - Urine

471

2341

1.35

8.30

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

330

1546

1.43

8.29

1.2

titre

97.5

169.5

0.84

(3000012) Reticulocyte production index

273

1237

1.48

8.17

1.6

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

279

1271

1.47

8.13

1.2

u/l

102.5

91.2

0.94

245

1096

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

133

508

1.75

8.04

1.5

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

106

378

1.87

7.99

2.9

3.1

ml/dl

14.8

14.7

0.11

357

(4010399)

2577

15281

1.13

7.92

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1469

8365

1.18

7.87

1.8

1.9

u/l

37.1

39.3

3.24

1215

7295

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

934

0.50

7.85

1.8

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

228

1005

1.52

7.81

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

273

1249

1.46

7.80

1.5

1.4

umol/l

15.6

13.2

4.68

251

1183

(3016650) Hepatitis A virus Ab [Presence] in Serum

562

2892

1.30

7.80

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6364

39593

1.09

7.76

3.0

3.3

mmol/l

2.5

2.74

5443

34685

(3008116) Ketones [Moles/volume] in Urine by Test strip

110

402

1.83

7.71

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

445

2223

1.34

7.63

3.3

3.7

—

(4034850)

1152

6444

1.20

7.59

15.3

9.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

849

4608

1.23

7.58

1.4

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

630

3308

1.28

7.50

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

359

1739

1.38

7.49

1.9

2.1

u/field

2.2

2.4

0.25

140

697

(40768795) Lymph node Pathology biopsy report

228

2224

0.68

7.41

1.2

—

(3025130) Human papilloma virus identified in Specimen

132

1446

0.61

7.40

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

5.62

7.40

1.4

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

28711

194444

0.93

7.39

5.9

4.8

mmol/l

6.4

6.0

280.93

26363

175374

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

258

2.02

7.33

1.4

73.0

71.7

0.13

215

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

994

7936

0.83

7.24

1.5

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

287

1.95

7.22

5.2

5.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

191

825

1.55

7.22

3.9

2.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

306

1454

1.41

7.17

1.3

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1136

6388

1.19

7.09

1.4

ug/g

255.7

263.7

0.66

698

3790

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

169

713

1.58

7.08

2.1

1.8

e6/l

15292.8

11915.6

0.27

392

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

573

2997

1.28

7.07

1.8

1.9

ug/l

23.9

25.0

0.16

554

2935

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

248

1138

1.46

7.03

1.9

u/field

3.0

2.3

0.43

157

808

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

138

556

1.66

6.95

1.4

21.8

23.2

0.23

111

470

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1072

6008

1.20

6.95

1.3

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

780

4238

1.23

6.93

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

107

402

1.78

6.91

1.4

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

342

1673

1.37

6.77

1.6

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

104

390

1.78

6.77

1.2

mg/l

54.2

28.4

0.19

297

(1002224) Polysomnography panel

898

7187

0.83

6.74

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

519

2707

1.28

6.58

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

297

1429

1.39

6.52

1.3

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

118

465

1.69

6.49

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

118

465

1.69

6.49

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

118

465

1.69

6.49

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

118

465

1.69

6.49

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

232

1073

1.44

6.37

1.1

u/l

46.0

23.0

1.84

160

815

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10754

68632

1.06

6.31

4.3

23.0

21.7

14.18

5112

33786

(3035947) Staphylolysin Ab [Units/volume] in Serum

223

1028

1.45

6.24

1.2

1.1

iu/ml

5.2

3.6

0.30

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

510

2674

1.28

6.23

1.3

1.2

u/ml

2.9

4.3

1.44

173

915

(3006442) Creatine [Moles/volume] in Serum or Plasma

278

1336

1.39

6.18

1.6

umol/l

70.6

73.5

0.26

(3023487) Leukocytes [#/volume] in Peritoneal fluid

184

818

1.50

6.17

2.1

2.0

e6/l

12148.2

2116.6

1.06

131

558

(3042010) Triglyceride [Moles/volume] in Pleural fluid

328

1.81

6.17

1.3

mmol/l

0.5

1.6

2.93

213

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

937

0.56

6.12

11.3

16.5

nmol/l

1439.4

1431.6

0.04

898

(3033923) Metanephrine [Moles/time] in 24 hour Urine

110

433

1.70

6.10

1.1

umol/24h

14.7

0.7

0.52

203

(3008898) HLA-B27 [Presence]

558

4632

0.80

6.06

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

385

0.33

6.03

1.2

1.5

—

(3027008) Opiates [Presence] in Urine

361

3157

0.76

6.01

1.9

1.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

213

2.01

5.99

1.3

1.1

u/l

17.6

19.9

0.49

141

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

274

1322

1.39

5.97

1.6

1.5

u/l

6.5

6.7

0.07

133

625

(3028300) Cannabinoids [Presence] in Urine

363

3168

0.76

5.96

1.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

229

1075

1.42

5.84

1.1

u/l

117.6

81.8

2.39

168

849

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

176

785

1.50

5.84

1.7

1.8

umol/l

88.2

115.5

1.12

401

(3027944) Amphetamines [Presence] in Urine

354

3089

0.76

5.82

1.9

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

575

3085

1.25

5.82

1.6

g/l

0.8

0.9

0.63

440

2284

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1077

8371

0.85

5.80

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

213

989

1.44

5.77

2.4

2.3

—

(3000764) Benzodiazepines [Presence] in Urine

362

3141

0.77

5.71

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

129

540

1.60

5.68

1.6

1.9

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

5.72

5.64

1.2

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

114

464

1.64

5.62

1.1

79.7

85.8

1.05

229

(3020191) Ethanol [Moles/volume] in Serum or Plasma

314

1565

1.34

5.61

1.4

promille

1.3

1.4

0.09

232

1210

(3015377) Calcium [Moles/volume] in Serum or Plasma

11063

70865

1.06

5.60

3.3

3.5

mmol/l

2.3

2.4

10.36

9592

60925

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

105

2.42

5.55

1.3

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

162

719

1.51

5.53

1.4

1.3

mmol/l

3.5

0.08

141

665

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

311

1.78

5.50

2.4

2.6

mg/l

76.5

62.0

0.21

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

114

467

1.63

5.49

1.2

94.7

104.9

1.59

102

430

(3016879) Cocaine [Presence] in Urine

342

2969

0.77

5.44

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

1028

5876

1.17

5.39

4.9

4.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

135

579

1.56

5.39

1.6

1.4

g/l

16.5

12.7

5.48

109

437

(3020491) Glucose [Moles/volume] in Blood

288

1427

1.35

5.37

2.1

1.9

mmol/l

7.6

7.2

1.32

212

983

(3017315) Amylase [Enzymatic activity/volume] in Urine

229

1093

1.40

5.37

1.2

u/l

211.4

347.1

1.75

217

1003

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

916

7160

0.85

5.33

1.4

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

284

1406

1.35

5.32

2.9

2.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

678

3741

1.21

5.30

1.5

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

800

6314

0.84

5.23

1.7

1.8

nmol/l

41.5

41.9

0.22

768

6127

(3050129) First trimester maternal screen panel - Serum or Plasma

501

0.45

5.23

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

28933

195381

0.94

5.20

6.1

4.6

mmol/l

3.9

4.7

307.65

27263

178229

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12607

81191

1.05

5.16

2.4

2.2

nmol/l

76.9

78.9

12.96

11172

71631

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

167

758

1.47

5.15

1.6

nmol/l

35.4

7.5

0.44

142

636

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

104

424

1.64

5.13

1.3

1.2

—

(3019225) pH of Specimen

3085

22337

0.91

5.12

5.5

4.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

968

5532

1.17

5.11

1.8

1.7

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

162

2.06

5.09

1.3

1.2

pmol/l

13.1

16.4

0.34

139

(3011544) Albumin [Mass/volume] in Pleural fluid

213

1.91

5.06

1.2

1.1

g/l

14.7

17.9

2.66

191

(3002385) Erythrocyte distribution width [Ratio]

24258

158932

1.05

5.06

27.7

18.4

14.1

13.8

149.19

23847

155483

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

964

5517

1.17

5.01

1.6

iu/ml

11.2

7.7

0.18

229

1228

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

119

2.24

5.01

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

316

1.73

4.99

1.4

1.2

85.6

84.8

0.06

(3037692) Legionella sp identified in Specimen by Organism specific culture

170

781

1.45

4.95

1.3

1.5

—

(3045414) Leukocytes [Presence] in Urine

1518

8990

1.13

4.88

2.3

1.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

109

457

1.59

4.84

1.2

73.7

86.6

2.29

230

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

232

1132

1.37

4.82

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.36

4.79

1.2

1.3

g/l

0.1

0.27

(3033799) Differential panel - Peritoneal fluid

157

715

1.47

4.79

1.8

2.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

121

522

1.55

4.77

1.4

g/l

28.4

39.5

0.46

107

396

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

123

1230

0.67

4.73

1.2

1.4

nmol/l

0.2

0.17

868

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

278

1404

1.32

4.63

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1870

13802

0.90

4.62

3.3

3.0

e9/l

4.5

4.1

7.64

1384

10204

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

120

1198

0.67

4.59

6.1

6.5

—

(4281824)

243

2153

0.75

4.57

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

322

1663

1.29

4.56

2.2

2.3

—

(4306422)

475

2570

1.24

4.56

1.3

1.2

—

(4146454)

476

2577

1.24

4.55

3.0

2.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

430

3546

0.81

4.52

1.3

iu/l

30.1

34.2

1.61

369

3001

(4268621)

331

1721

1.29

4.46

2.4

2.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

317

1.68

4.45

1.4

1.2

75.5

76.9

0.11

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

287

1.72

4.45

4.9

5.4

ug/min

44.6

49.7

0.38

240

(3037556) Urate [Mass/volume] in Serum or Plasma

141

639

1.47

4.44

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1187

6965

1.14

4.44

1.3

1.2

u/ml

0.7

0.9

0.46

118

609

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

570

3154

1.21

4.41

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1878

11332

1.11

4.40

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

160

747

1.43

4.33

1.3

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

290

1.70

4.30

1.4

1.3

19.9

27.0

1.21

224

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

445

2411

1.23

4.25

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

173

1593

0.72

4.24

4.4

5.2

u/ml

34.2

120.5

4.58

470

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

263

0.33

4.24

1.4

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

313

1628

1.28

4.23

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

389

2079

1.25

4.21

1.4

1.3

mosm/kgh2o

278.8

277.3

0.56

311

1592

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

233

1.78

4.17

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

239

2091

0.76

4.15

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

245

2134

0.76

4.12

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

376

2009

1.25

4.09

3.2

3.0

mg/l

64.6

45.9

0.48

276

1449

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

401

0.47

4.08

2.0

1.7

—

(3044007) Cell count panel - Peritoneal fluid

141

651

1.45

4.08

2.0

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

240

2092

0.76

4.06

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

323

1.63

3.96

1.4

1.2

ng/l

111.2

374.9

0.54

221

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

268

2294

0.78

3.95

1.2

1.1

u/ml

3.0

1.3

0.80

905

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

391

2109

1.24

3.93

1.4

1.3

—

34.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

444

2431

1.22

3.88

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

811

0.63

3.88

1.0

1.1

u/ml

5.9

5.8

0.01

119

(3000475) Leukocytes [#/volume] in Synovial fluid

929

5416

1.15

3.87

1.5

1.6

e6/l

15170.8

14512.1

0.17

680

3912

(3014148) Varicella zoster virus Ab [Titer] in Serum

331

1756

1.26

3.86

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.50

3.85

1.3

1.4

ug/l

142.4

104.5

0.34

(3015076) Soybean IgE Ab [Units/volume] in Serum

584

0.57

3.84

1.1

1.0

u/ml

0.5

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

224

1131

1.32

3.82

1.6

1.4

u/l

7.7

5.7

1.24

196

940

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

816

0.64

3.82

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

357

1918

1.24

3.74

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

5254

33290

1.06

3.70

1.5

g/l

2.7

2.6

3.05

3143

19319

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

454

2505

1.21

3.69

1.2

1.1

111.4

117.6

3.05

416

2234

(3010726) Horse dander IgE Ab [Units/volume] in Serum

198

1746

0.76

3.69

1.1

u/ml

2.0

1.6

0.24

409

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

153

733

1.39

3.66

1.1

u/ml

1.5

15.4

1.60

(3047189) Immunofixation for 24 hour Urine

213

1079

1.32

3.58

1.6

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

473

2630

1.20

3.57

1.1

g/l

1.6

1.5

5.35

428

2369

(3004716) Salmonella sp identified in Stool by Organism specific culture

1246

7446

1.12

3.55

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.13

3.54

6.2

3.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

132

1227

0.72

3.51

1.0

u/ml

1.5

0.4

0.46

303

(3014133) Dog dander IgE Ab [Units/volume] in Serum

168

1504

0.74

3.51

1.1

1.0

u/ml

4.8

3.1

0.52

579

(3023103) Potassium [Moles/volume] in Serum or Plasma

30931

207986

0.94

3.50

29.9

17.3

mmol/l

4.0

232.78

30423

202395

(1001926) Buprenorphine [Presence] in Urine by Screen method

291

2427

0.80

3.50

1.9

2.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

132

0.25

3.50

2.4

7.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

540

0.58

3.44

1.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

213

1086

1.31

3.43

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

213

1086

1.31

3.43

1.3

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

22161

145442

1.04

3.42

4.1

3.9

pmol/l

15.1

15.0

5.79

20212

130121

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

351

1903

1.23

3.42

1.2

1.1

91.5

96.9

3.18

337

1761

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

203

1.74

3.42

1.1

umol/24h

8.9

1.7

0.53

203

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

122

570

1.43

3.39

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.20

3.33

1.1

1.2

ng/l

6268.8

2616.9

0.60

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

138

662

1.39

3.32

1.4

1.3

ug/l

153.0

306.1

0.88

355

(3014599) Egg white IgE Ab [Units/volume] in Serum

675

0.63

3.31

1.1

1.0

u/ml

0.5

0.8

0.86

168

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

28746

193609

0.95

3.30

6.1

4.5

mmol/l

1.3

1.5

307.65

26943

175499

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

531

3007

1.18

3.30

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

242

2043

0.79

3.26

1.1

u/ml

2.2

3.3

1.23

102

956

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

463

2594

1.19

3.26

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

191

1656

0.77

3.20

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.92

3.20

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

444

0.56

3.20

1.5

1.8

—

(4211845)

204

1046

1.30

3.19

3.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

877

0.68

3.18

1.1

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

353

1935

1.22

3.14

1.4

g/l

7.0

6.8

0.38

256

1307

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

721

0.66

3.10

1.1

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

352

1933

1.22

3.08

1.4

g/l

0.4

0.49

260

1309

(3012898) Urea [Moles/volume] in Urine

200

1.70

3.07

1.5

1.3

mmol/l

131.6

170.9

1.97

172

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4625

29358

1.06

3.06

1.3

u/ml

14.4

14.0

0.12

1744

10554

(3028192) IgG subclass 2 [Mass/volume] in Serum

352

1935

1.22

3.05

1.4

g/l

2.8

3.0

1.24

258

1308

(3014271) Vancomycin [Susceptibility]

241

1272

1.27

3.03

3.1

3.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.71

2.99

1.1

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

264

1.59

2.96

3.0

3.3

umol/l

41.2

0.00

228

(4062490)

350

1930

1.21

2.96

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

203

1.68

2.92

1.8

1.6

umol/l

51.2

44.2

0.63

203

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

501

2856

1.17

2.92

2.4

2.0

mg/l

21.9

28.2

2.26

138

750

(3011335) Digoxin [Mass/volume] in Serum or Plasma

193

1.69

2.92

2.1

2.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

454

1.44

2.91

2.5

2.4

mmol/l

7.9

7.5

0.46

280

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

8.00

2.90

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

241

2004

0.80

2.90

1.1

u/ml

5.3

3.8

0.39

791

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

115

549

1.40

2.90

1.4

1.3

30.9

37.7

1.23

354

(3015183) Erythrocyte sedimentation rate

717

0.67

2.89

1.6

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

144

1.81

2.88

3.4

5.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

639

3715

1.15

2.88

3.3

3.5

1.4

1.5

0.23

491

2863

(3023430) Cat dander IgE Ab [Units/volume] in Serum

162

1412

0.76

2.87

1.1

1.0

u/ml

1.3

2.9

2.66

543

(3034426) Prothrombin time (PT)

120

579

1.38

2.85

1.4

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

237

1968

0.80

2.82

1.1

u/ml

1.2

1.1

0.04

791

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

250

2062

0.81

2.80

1.8

1.9

titre

240.0

2312.5

—

107

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

361

1.48

2.73

1.1

—

(44806420)

132

652

1.35

2.73

2.2

2.4

—

(3006462) Nitrate [Presence] in Urine

186

965

1.29

2.72

3.4

3.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.54

2.71

4.0

3.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

519

2990

1.16

2.68

1.1

iu/ml

357.6

4432.1

0.55

591

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

608

0.66

2.65

2.5

nmol/l

121.2

150.1

1.69

526

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

121

594

1.36

2.62

1.4

pmol/l

17.3

15.6

0.80

100

495

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

120

589

1.36

2.60

1.1

1.3

20.6

22.1

0.07

(3009871) Measles virus Ab [Titer] in Serum

116

567

1.37

2.58

1.4

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

180

1.67

2.57

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

249

1349

1.23

2.56

1.9

2.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

306

1693

1.21

2.56

1.5

1.6

u/ml

25.3

25.5

0.02

359

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

218

1164

1.25

2.55

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

264

1440

1.22

2.54

1.3

titre

357.8

472.9

0.16

124

(3019420) Tryptase [Mass/volume] in Serum or Plasma

167

864

1.29

2.53

1.4

1.6

ug/l

11.7

9.1

0.47

153

785

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

218

1166

1.25

2.52

1.1

—

(3022689) Creatine [Moles/volume] in Urine

121

599

1.35

2.50

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1387

10051

0.92

2.49

1.1

1.2

iu/ml

126.1

136.4

0.37

467

3563

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

123

1088

0.75

2.49

4.5

5.6

u/ml

46.9

3972.5

0.69

208

(3003129) Base excess in Capillary blood by calculation

120

595

1.35

2.46

1.6

1.8

mmol/l

0.2

0.7

0.68

110

564

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4916

31447

1.05

2.45

1.3

iu/ml

45.8

40.5

0.87

1485

9845

(3002621) Streptococcal DNAse B [Units/volume] in Serum

173

1.66

2.43

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

233

1262

1.23

2.42

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

691

5177

0.89

2.41

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

203

1084

1.25

2.40

3.6

3.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7287

50179

0.96

2.37

2.9

3.0

ug/l

0.8

0.19

5016

33440

(3006270) Folate [Moles/volume] in Blood

309

1726

1.20

2.36

1.2

nmol/l

335.4

344.4

0.29

229

1409

(3020618) Glucose [Moles/volume] in Synovial fluid

1.98

2.35

1.0

mmol/l

6.2

5.1

0.78

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

665

3938

1.13

2.35

1.2

u/ml

8.7

15.6

0.42

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

120

600

1.34

2.35

1.1

—

(3023410) Appearance of Cerebral spinal fluid

235

1907

0.82

2.32

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

747

4458

1.12

2.32

4.2

3.4

mg/l

29.3

28.0

0.38

503

2815

(3011288) Drugs identified in Urine by Screen method

247

1994

0.82

2.31

3.7

2.8

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

145

1.70

2.31

1.4

1.5

42.7

40.5

0.11

(3020650) Glucose [Presence] in Urine

484

0.65

2.30

1.6

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

106

522

1.36

2.29

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

130

1126

0.77

2.28

1.4

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

125

632

1.32

2.28

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

140

720

1.30

2.26

1.6

1.8

u/ml

97637.1

24370.9

0.35

109

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.18

2.26

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

392

0.61

2.26

2.2

1.9

ug/l

2.2

6.3

1.21

224

(3039162) Centromere protein B Ab [Units/volume] in Serum

391

2239

1.17

2.25

1.3

1.2

u/ml

48.6

61.6

0.53

142

(3020874) Milk IgE Ab [Units/volume] in Serum

695

0.71

2.24

1.1

u/ml

0.4

1.2

2.12

209

(3019550) Sodium [Moles/volume] in Serum or Plasma

30907

207438

0.96

2.23

29.7

17.2

mmol/l

139.4

139.7

61.57

30443

202158

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

205

1677

0.81

2.21

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

279

0.55

2.18

1.5

1.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

172

0.43

2.18

1.1

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

363

1.42

2.17

1.1

pmol/l

11.3

7.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

254

1406

1.21

2.17

1.3

titre

142.0

60.7

0.46

115

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

143

1.68

2.16

1.1

u/l

11.0

11.1

0.01

143

(3032057) Clostridioides difficile [Presence] in Stool

477

1.36

2.14

1.9

1.8

—

(3002619) Bacteria identified in Specimen by Culture

432

1.38

2.13

1.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

201

1.56

2.12

2.1

2.3

60.9

59.3

0.10

120

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

146

763

1.28

2.11

2.9

2.1

ug/l

25.2

325.6

1.42

138

724

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

109

1.78

2.10

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

466

2721

1.14

2.09

1.3

1.4

—

(3000285) Sodium [Moles/volume] in Blood

289

1.45

2.07

1.1

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

852

0.75

2.05

12.3

12.8

mmol/l

0.6

0.16

778

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

461

2696

1.14

2.03

1.3

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.99

2.03

1.1

nmol/l

244.0

273.1

0.38

(3034274) Bile acid [Moles/volume] in Serum --fasting

157

833

1.26

2.02

1.2

1.5

umol/l

9.9

13.7

0.61

107

589

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1090

6685

1.09

2.02

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

461

2702

1.14

1.97

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

460

2698

1.14

1.95

1.3

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

117

1.71

1.95

1.2

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

1.94

0.0

5.9

—

0.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

1.94

0.0

2.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

28248

186973

1.04

1.94

5.5

4.1

mmol/l

1.4

1.3

36.98

26316

167964

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

480

1.33

1.94

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

121

626

1.29

1.92

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

18640

126022

0.97

1.90

3.6

3.2

u/l

65.6

53.9

30.43

17222

115942

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.82

1.90

1.5

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

165

890

1.24

1.87

1.2

1.3

59.9

60.6

0.03

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

174

944

1.23

1.87

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

160

1.58

1.87

1.9

2.3

12.7

17.4

0.51

(3024522) Salmonella sp identified in Specimen by Organism specific culture

464

2733

1.13

1.86

1.3

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

169

0.47

1.85

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

150

802

1.25

1.84

2.0

2.3

umol/l

61.7

55.4

1.37

100

646

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

474

2799

1.13

1.83

1.3

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

101

872

0.77

1.81

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

158

853

1.24

1.79

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

105

1.72

1.79

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

367

1.36

1.77

1.6

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

208

1656

0.84

1.77

4.1

3.1

13.5

13.3

1.59

203

1629

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

184

1.52

1.76

1.2

1.1

iu/ml

14.3

19.6

0.33

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

500

2974

1.12

1.74

1.2

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

343

1991

1.15

1.73

1.1

iu/ml

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

196

1087

1.20

1.72

1.4

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

169

1.54

1.72

1.4

1.3

ml/s/173m2

0.8

1.1

0.68

110

(4133840)

103

531

1.29

1.72

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

148

1.58

1.71

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

196

1088

1.20

1.71

1.4

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3501

24306

0.96

1.70

3.4

4.2

ug/l

15.2

26.8

2.70

2879

20047

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

248

1408

1.18

1.68

1.0

1.1

mg/l

295.3

285.8

1.10

225

1247

(21494567) Legionella sp IgM Ab [Presence] in Serum

151

1.55

1.59

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

471

2810

1.12

1.59

1.5

65.4

58.8

3.35

319

1757

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

450

1.31

1.58

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

638

4673

0.91

1.58

1.8

1.9

pmol/l

190.8

201.2

1.68

604

4419

(21494434) Karyotype in Bone marrow

339

1985

1.14

1.55

1.1

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.89

1.54

1.1

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

126

1.59

1.53

1.4

1.5

11.6

12.9

0.17

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.03

1.53

2.8

1.8

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.75

1.52

1.1

u/l

273.7

464.8

0.62

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

174

1384

0.84

1.51

1.3

u/l

36.1

32.3

0.71

143

1111

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

345

0.68

1.49

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

123

664

1.24

1.46

1.1

miu/ml

1773.6

1550.6

1.25

123

664

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

123

1.57

1.44

1.1

1.2

nmol/l

0.1

0.2

0.23

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.87

1.43

1.1

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

639

3904

1.09

1.40

1.3

1.2

u/ml

2.1

6.4

2.45

280

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5772

37489

1.03

1.38

1.3

1.2

u/ml

1.5

1.8

1.35

1577

9363

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

357

2117

1.13

1.38

1.4

1.5

23.5

29.7

2.87

228

1305

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

133

0.50

1.37

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

275

1.36

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

125

1.55

1.36

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

136

750

1.21

1.34

2.7

3.0

umol/l

30.6

28.8

0.82

102

571

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

492

1.26

1.34

2.2

2.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.97

1.34

2.9

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

174

982

1.18

1.34

1.2

1.1

ratio

1.1

0.87

343

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

752

4639

1.08

1.33

1.3

u/ml

7.7

6.6

0.25

128

738

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

125

686

1.22

1.30

2.0

—

(3018133) Calcium [Moles/volume] in Urine

255

1.36

1.29

1.4

1.7

mmol/l

2.3

2.6

0.57

224

(3013166) Neutrophils/100 leukocytes in Synovial fluid

126

693

1.21

1.29

1.3

1.4

66.5

56.1

2.69

105

598

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

204

1171

1.16

1.29

1.4

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

359

2141

1.12

1.28

1.3

1.4

e6/l

176679.4

121712.7

0.62

251

1474

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

204

1172

1.16

1.27

1.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

204

1172

1.16

1.27

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

204

1172

1.16

1.27

1.4

1.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

742

4585

1.08

1.27

1.3

u/ml

6.5

5.3

0.17

480

(3044290) Cell count panel - Cerebral spinal fluid

547

3984

0.91

1.27

1.2

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

415

2498

1.11

1.26

3.7

3.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

747

0.80

1.26

1.8

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.87

1.25

5.1

3.0

27.1

21.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

106

864

0.82

1.25

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

485

0.76

1.25

2.3

1.8

mg/l

8.3

8.9

0.39

387

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

217

1.38

1.24

1.2

ug/l

81.9

112.0

1.25

130

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

234

1362

1.15

1.24

2.4

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

356

2128

1.12

1.23

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

552

1.23

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

292

1.33

1.23

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

156

1.45

1.22

1.4

1.5

—

(3007147) Virus identified in Stool by Electron microscopy

2.78

1.22

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

190

1.40

1.20

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

639

0.79

1.20

1.8

3.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

179

1.42

1.20

1.3

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

1.19

0.0

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

1639

10415

1.05

1.19

1.4

1.3

u/ml

241.9

260.9

0.30

1503

9596

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1134

7132

1.06

1.19

1.1

u/ml

13.8

8.7

0.15

102

(3024263) Appearance of Synovial fluid

203

1174

1.15

1.18

1.5

1.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

294

1.32

1.18

1.3

1.4

42.2

51.0

0.70

133

(3032352) Blasts [#/volume] in Cerebral spinal fluid

233

0.66

1.18

1.5

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

388

1.27

1.18

1.2

—

(40758292) HTLV I+II Ab panel - Serum

327

0.71

1.17

1.2

1.4

—

(3022475) Manganese [Moles/volume] in Blood

106

0.50

1.16

1.9

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

431

2613

1.10

1.16

3.1

3.4

nmol/l

8.2

8.8

0.09

415

2546

(40768441) Liver Pathology biopsy report

199

1524

0.87

1.15

1.3

1.4

—

(3028433) Virus identified in Specimen by Culture

128

715

1.19

1.15

1.1

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

131

1.48

1.14

2.1

1.3

mmol/l

25.4

21.7

2.15

(3010838) Calcium [Moles/time] in 24 hour Urine

139

1092

0.85

1.13

1.7

1.6

mmol/24h

5.4

5.5

—

(3019174) dRVVT (LA screen)

148

1.44

1.12

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

285

0.70

1.11

8.2

7.9

umol/l

1.3

0.3

0.64

260

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

129

724

1.19

1.11

1.1

93.9

100.1

1.55

568

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

173

0.62

1.11

1.1

u/ml

0.0

0.7

—

112

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

800

4990

1.07

1.10

1.3

1.2

u/ml

44.9

38.0

0.27

269

(40761995) Spermatozoa Progressive [#/volume] in Semen

131

0.56

1.09

3.3

2.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

246

1.33

1.08

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

246

1.33

1.08

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

246

1.33

1.08

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

490

3555

0.92

1.08

1.7

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

472

2888

1.09

1.07

1.6

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

130

0.56

1.07

6.5

5.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

202

1179

1.14

1.07

2.2

2.9

37.5

37.8

0.05

375

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

382

1.26

1.07

2.1

3.1

—

(40768443) Skin Pathology biopsy report

1359

9520

0.95

1.06

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

265

1.31

1.05

1.7

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

342

1.27

1.04

1.1

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3112

21409

0.97

1.03

1.8

1.6

1.5

7.39

2619

18474

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

251

1490

1.12

1.03

3.2

3.6

nmol/l

129.8

145.0

0.38

251

1466

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

330

2431

0.90

1.03

1.1

au/ml

14.5

11.3

0.40

112

(21494815) CD4 cells/100 lymphocytes in Specimen

231

1735

0.89

1.02

1.9

2.1

48.1

37.5

2.86

209

(3006969) Lambda light chains [Mass/volume] in Urine

1.73

1.02

1.0

1.1

g/l

0.2

0.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

1.01

0.0

1.6

—

13.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.00

1.01

0.0

1.0

—

0.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

1.00

0.0

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

262

1.30

0.98

1.6

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

380

2315

1.10

0.97

3.1

3.5

63.9

58.4

4.52

233

1490

(44816559) Phosphatidylethanol [Mass/volume] in Blood

511

3154

1.08

0.97

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.70

0.97

1.2

1.1

mmol/l

—

(3027035) Albumin [Mass/time] in 24 hour Urine

199

1.34

0.96

1.3

1.4

—

430.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

539

1.20

0.96

1.5

1.6

ug/l

10.0

9.3

0.74

539

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

148

1.40

0.95

1.1

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

311

1.27

0.95

1.6

1.7

pmol/l

94.0

53.1

0.92

253

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.95

0.95

1.1

1.3

—

(3001729) Color of Synovial fluid

183

1.35

0.93

1.3

1.7

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.22

0.93

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

2.22

0.93

2.7

8.8

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

110

1.46

0.91

1.4

2.4

1.6

0.38

(3035611) Eosinophils/100 leukocytes in Synovial fluid

155

1.38

0.91

1.4

1.8

1.2

0.7

0.31

126

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

165

1254

0.88

0.91

1.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.52

0.90

1.4

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

356

2174

1.09

0.89

1.2

mmol/l

7.9

7.5

1.16

259

1566

(3036670) Protein [Mass/volume] in Synovial fluid

124

710

1.17

0.89

1.1

1.3

g/l

39.2

40.6

0.42

376

(3023420) DNA double strand Ab [Units/volume] in Serum

314

1907

1.10

0.89

1.7

1.4

iu/ml

40.3

23.8

0.70

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

315

1.25

0.87

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.51

0.86

10.6

8.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

113

0.59

0.86

1.0

1.2

1.4

—

113

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

306

1860

1.10

0.86

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

560

3490

1.07

0.86

1.3

1.2

u/ml

33.4

49.1

2.16

329

(3005011) Chlamydia sp Ab [Titer] in Serum

224

0.71

0.86

1.8

1.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

300

0.76

0.85

2.3

3.2

ng/l

50.3

130.6

2.15

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

254

0.74

0.84

2.0

umol/l

15.3

18.1

0.77

254

(3019768) Coxiella burnetii Ab [Presence] in Serum

118

1.41

0.84

1.5

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

103

585

1.17

0.83

1.5

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

403

0.79

0.83

4.1

5.2

u/l

58.0

53.4

0.09

152

(3020717) Zinc [Moles/volume] in Serum or Plasma

135

784

1.15

0.82

1.3

1.5

umol/l

16.8

25.0

3.79

128

741

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

730

5154

0.94

0.82

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

186

1104

1.12

0.82

1.3

g/l

1.5

0.03

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

256

1881

0.91

0.81

1.1

au/ml

55.5

72.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

206

0.71

0.81

1.1

1.0

ug/l

112.0

86.5

0.91

148

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.81

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.67

0.80

1.1

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

113

650

1.16

0.79

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

101

782

0.86

0.76

1.3

1.4

—

(40762814) Titanium [Mass/volume] in Blood

464

0.82

0.76

2.1

2.3

ug/l

3.2

3.6

0.58

162

(3004446) Plasmodium sp identified in Blood by Light microscopy

156

0.68

0.75

2.4

2.7

—

(3013862) HLA-DP [Type]

0.55

0.74

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

490

3488

0.94

0.74

1.7

1.8

mu/l

298.6

296.5

0.04

452

3230

(1175426) CD3 cells/100 lymphocytes in Blood

241

1462

1.10

0.74

1.8

2.0

72.5

71.6

0.42

221

1399

(3006245) CD3-CD19+ cells/100 cells in Blood

109

630

1.15

0.74

1.6

2.1

11.4

10.3

0.26

570

(3000494) Fungus identified in Specimen by Culture

3723

24287

1.02

0.73

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

123

0.65

0.72

1.2

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

200

1474

0.90

0.71

1.7

2.5

e6/l

533.3

690.5

1.03

606

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

386

0.81

0.70

1.8

1.6

au/ml

30.0

51.9

—

(3044009) aPTT.lupus sensitive (LA screen)

152

1.32

0.69

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.55

0.68

1.5

1.3

nmol/l

332.3

546.2

1.20

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.67

0.68

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

543

0.85

0.67

1.7

1.5

ug/l

0.4

0.32

348

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

557

0.85

0.66

1.5

1.2

nmol/l

113.1

133.7

0.61

401

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

190

0.74

0.66

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

220

0.76

0.66

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

136

1.32

0.65

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

182

0.73

0.65

1.5

2.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

520

0.85

0.65

1.1

—

(4024509)

295

2125

0.93

0.65

1.7

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

118

694

1.13

0.65

1.3

1.2

g/l

0.2

0.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

628

4412

0.95

0.64

1.1

u/ml

13.8

8.4

0.47

433

(3023511) Choriogonadotropin [Units/volume] in Urine

520

1.15

0.64

1.5

1.2

—

(40763590) HLA-DQ beta [Type]

0.57

0.63

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

369

2299

1.07

0.63

2.1

2.3

titre

9.4

6.4

—

(40760410) HLA-B [Type] by High resolution

0.56

0.63

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.56

0.63

1.0

—

(40760409) HLA-A [Type] by High resolution

0.56

0.63

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

226

0.77

0.63

2.0

2.4

mmol/l

8.2

7.1

1.35

105

(3017509) Phencyclidine [Presence] in Urine

111

0.66

0.63

1.2

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

109

640

1.14

0.62

1.6

2.0

31.4

30.3

0.25

598

(3035933) Granulocytes/100 leukocytes in Blood

394

0.83

0.61

2.7

1.8

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

0.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

558

3922

0.95

0.60

1.3

1.4

u/l

10.5

9.7

0.65

452

3166

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.60

0.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.60

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.60

0.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

313

1.19

0.60

1.4

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.82

0.60

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.82

0.60

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

234

1.23

0.59

4.5

2.7

mg/l

1.6

1.2

0.84

169

(43055514) Macroprolactin [Presence] in Serum or Plasma

210

1.24

0.59

1.8

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1152

7417

1.04

0.58

1.1

titre

287.5

225.2

0.25

187

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

723

5039

0.96

0.57

2.6

3.4

u/ml

1523.9

740.7

0.66

657

4575

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

108

0.68

0.56

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

106

627

1.13

0.56

1.7

2.1

u/l

29.9

46.0

0.88

570

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1220

8411

0.97

0.56

2.9

3.5

u/ml

3296.3

1220.5

0.45

1009

7252

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

309

0.82

0.55

1.8

2.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.38

0.55

1.0

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.50

0.55

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.50

0.55

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

138

0.72

0.54

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

323

0.83

0.54

1.1

u/ml

0.4

1.0

1.20

163

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.48

0.54

1.6

1.4

0.8

0.5

0.48

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

220

0.79

0.54

5.2

5.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

153

1.26

0.53

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

454

1.15

0.53

2.8

3.1

mg/l

6.1

7.6

1.66

363

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

153

928

1.10

0.53

1.4

2.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.54

0.52

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

153

929

1.10

0.52

1.4

2.1

—

(3044941) Cell count panel - Synovial fluid

547

3477

1.05

0.52

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

120

887

0.90

0.51

1.1

u/l

1.2

1.1

0.38

456

(3038177) Helicobacter pylori Ab [Presence] in Serum

385

2716

0.94

0.50

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

101

1.32

0.50

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

419

1.15

0.50

2.5

au/ml

88.1

164.8

1.33

(3034614) HLA Ag [Interpretation]

1.61

0.50

1.4

1.3

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

105

0.70

0.50

1.0

1.3

u/field

0.8

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.64

0.50

1.1

1.2

mg/l

1.4

1.9

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

120

0.72

0.49

1.6

1.3

umol/24h

292.1

349.5

0.54

120

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.42

0.49

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

389

1.15

0.49

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

113

835

0.90

0.48

1.1

ng/l

791.9

706.1

0.06

210

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

253

0.82

0.48

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.51

0.48

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.35

0.47

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

1.33

0.46

2.0

2.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

555

1.12

0.46

1.2

g/l

0.3

0.71

454

(3030313) Adrenal Ab [Titer] in Serum

1.32

0.46

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.40

0.46

1.2

1.1

umol/24h

0.2

0.8

—

(3011412) CD3 cells [#/volume] in Blood

301

1892

1.06

0.45

1.8

2.4

e9/l

1.1

0.21

196

1135

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

153

939

1.09

0.44

1.5

2.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

104

766

0.91

0.43

1.5

umol/l

27.9

29.3

0.76

740

(40765096) Chromosome analysis panel by Banding

675

0.90

0.43

1.1

1.2

—

(4015189)

109

660

1.10

0.42

2.1

2.3

—

(3036180) Methadone [Presence] in Urine

0.00

0.42

0.0

2.7

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

230

1438

1.07

0.42

1.8

2.0

14.8

15.4

0.24

579

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

143

1035

0.92

0.42

1.3

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.41

0.0

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

245

1.17

0.41

2.3

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

153

0.78

0.41

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1865

12704

0.98

0.41

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.30

0.41

1.0

pmol/l

158.7

167.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

1111

1.07

0.41

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

319

0.86

0.40

1.1

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.40

0.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

115

0.75

0.40

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

656

4222

1.04

0.39

1.5

1.7

iu/l

33.2

9.1

0.60

215

1356

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

318

0.86

0.39

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

253

1.16

0.39

2.3

2.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.42

0.38

1.1

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

136

838

1.08

0.38

1.3

1.2

mmol/l

6.1

0.09

119

794

(3007733) Chloride [Moles/volume] in Urine

1.33

0.38

1.1

1.2

mmol/l

84.9

82.7

—

(3045142) Bone marrow Pathology biopsy report

372

2598

0.95

0.38

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

443

1.11

0.37

1.2

2.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

143

0.79

0.37

1.6

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.73

0.37

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.64

0.36

1.0

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

412

1.12

0.36

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.73

0.36

1.0

1.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.26

0.36

1.6

mg/l

1.0

1.7

0.51

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.43

0.36

1.8

2.4

mu/l

2.2

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

120

0.78

0.35

1.8

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

142

0.80

0.35

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

426

1.11

0.35

6.4

5.9

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

406

0.89

0.35

2.7

u/l

2837.9

1692.2

0.33

359

(3018291) Platelet Ab [Presence] in Serum

1.38

0.35

1.0

1.1

—

(3036603) Volume of Urine

233

1470

1.06

0.35

1.6

1764.2

1967.1

1.19

362

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

214

0.84

0.34

2.4

2.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

250

1581

1.06

0.34

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.33

0.34

1.2

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.68

0.34

1.0

1.2

u/ml

0.4

0.8

—

(3028707) Methadone [Presence] in Urine by Screen method

199

1407

0.94

0.34

2.2

2.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.25

0.33

1.6

2.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

133

0.80

0.32

1.1

u/ml

0.0

0.9

0.80

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

214

1.15

0.32

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

185

1164

1.06

0.31

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

421

2915

0.96

0.31

1.2

1.3

miu/ml

194.9

202.3

0.10

1080

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.33

0.31

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

513

1.09

0.31

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.29

0.31

1.1

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

204

0.85

0.31

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

259

1.13

0.31

1.1

1.3

mmol/l

6.2

6.8

0.37

122

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.30

0.30

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

183

1153

1.06

0.30

1.2

—

(44806071)

232

0.86

0.30

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

183

1154

1.06

0.30

1.0

1.1

nmol/l

5.7

6.3

0.08

239

(3016228) CD19 cells/100 cells in Blood

135

844

1.07

0.29

2.1

2.0

6.1

8.5

2.71

126

824

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

179

1261

0.95

0.29

1.1

mg/l

43.3

46.8

0.47

155

1063

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

160

1.17

0.29

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

195

1235

1.05

0.28

1.4

1.3

u/ml

1.8

1.4

0.26

108

640

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

166

0.84

0.27

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

152

957

1.06

0.27

1.2

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

26631

177991

0.99

0.27

5.1

4.7

mu/l

2.2

2.1

0.43

24439

160346

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

171

1203

0.95

0.27

1.1

mg/l

303.5

314.8

0.24

151

1065

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

231

1611

0.96

0.26

1.0

ng/l

39.7

43.4

0.68

147

1116

(3000060) B lymphocytes [#/volume] in Blood

438

0.91

0.26

1.7

1.9

e6/l

482.8

1523.3

0.77

226

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

230

1602

0.96

0.25

1.0

ng/l

288.6

324.7

1.33

150

1128

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

131

1.17

0.25

2.7

2.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

169

1071

1.05

0.25

1.4

1.5

3.0

3.9

0.52

238

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

231

1608

0.96

0.25

1.0

ng/l

707.6

733.3

0.37

144

1087

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.81

0.24

1.5

1.6

—

(3027874) Urate [Moles/volume] in Urine

1.23

0.24

1.0

1.1

mmol/l

1.5

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

293

2026

0.96

0.23

1.4

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

671

4580

0.98

0.23

1.3

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

421

0.92

0.23

1.1

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

200

1277

1.04

0.23

1.6

2.0

nmol/l

15.6

16.1

0.47

183

1185

(3041184) Isoniazid [Presence] in Urine

1.24

0.22

3.2

2.7

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.82

0.22

1.2

nmol/l

14.7

24.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

220

1527

0.96

0.22

1.2

1.3

mmol/l

2.2

0.15

202

1420

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.22

0.0

1.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.22

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.22

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.22

0.0

1.1

—

(3022670) pH of Venous cord blood

0.00

0.22

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

485

1.07

0.22

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

972

6599

0.98

0.21

1.5

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

133

0.85

0.21

5.8

4.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.29

0.21

1.3

mmol/24h

1.7

2.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

245

0.90

0.20

1.2

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.25

0.20

1.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

500

0.93

0.20

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

0.88

0.19

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

7695

51581

0.99

0.19

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.17

0.19

1.1

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

108

684

1.05

0.18

1.6

1.4

iu/ml

1542785.0

2247213.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

236

1522

1.03

0.18

1.2

u/ml

14.4

5.8

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

1.23

0.18

1.6

1.7

nmol/l

293.3

223.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

418

1.07

0.18

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

231

1.10

0.18

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

312

0.92

0.18

1.4

2.2

—

(37021550) Renin [Units/volume] in Plasma --upright

470

0.94

0.18

1.2

mu/l

124.0

57.8

1.34

338

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

291

0.92

0.18

1.1

1.3

100.8

97.7

0.43

286

(40763480) Human metapneumovirus Ag [Presence] in Specimen

104

1.15

0.18

1.0

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

201

1295

1.04

0.17

1.6

2.5

e6/l

466.4

554.8

1.26

158

1103

(3036048) Francisella tularensis Ab [Titer] in Serum

462

0.94

0.17

1.2

titre

568.0

692.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

290

0.92

0.17

1.1

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

481

0.94

0.16

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

199

0.90

0.16

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

421

1.06

0.16

1.2

umol/l

16.1

16.6

0.26

377

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.84

0.15

1.1

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

101

0.86

0.15

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

150

1.11

0.15

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

526

1.05

0.15

1.2

113.6

112.9

0.09

469

(3047007) Chlamydophila sp Ab [Presence] in Serum

335

2287

0.98

0.15

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

234

1.08

0.15

1.1

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

1.5

1.9

0.29

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

0.5

1.5

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

1.2

2.0

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

3.0

3.4

0.10

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

2.1

2.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

0.6

1.5

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

0.5

1.1

0.64

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

3.2

1.9

0.37

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.15

0.15

1.6

1.5

mg/l

1.9

2.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

253

0.92

0.14

1.2

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.18

0.14

1.1

1.0

—

(3013762) Body weight Measured

0.82

0.14

1.1

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

114

0.88

0.14

2.1

1.9

umol/l

1.4

0.26

100

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

132

1.11

0.13

1.1

1.2

mg/l

42.6

44.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

343

2336

0.98

0.13

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

229

1.08

0.13

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.19

0.13

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

443

0.95

0.13

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

717

4847

0.99

0.13

1.3

mg/l

562.1

573.2

0.14

679

4607

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

301

1.06

0.12

2.0

2.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

120

0.89

0.12

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

285

0.94

0.12

1.3

1.5

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

146

1.10

0.12

2.1

2.9

pmol/l

17.0

52.4

0.65

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

168

0.91

0.12

1.1

—

(3010503) CD19 cells [#/volume] in Blood

197

1281

1.03

0.11

2.0

2.6

e9/l

0.1

0.4

2.72

185

1243

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

179

1.08

0.11

1.1

1.0

—

(3024316) Viscosity of Plasma

108

1.11

0.11

1.2

2.2

mpas

1.5

1.8

2.80

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

134

1.10

0.11

1.6

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

249

0.94

0.10

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

639

4211

1.01

0.10

1.3

1.4

e6/l

15.1

33.2

2.17

524

3223

(3048689) Calprotectin [Mass/mass] in Stool

3117

20894

0.99

0.10

2.1

2.2

ug/g

180.0

149.1

3.48

2505

16231

(4212803)

221

0.94

0.10

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

231

1572

0.98

0.10

1.8

2.0

ug/l

4.8

3.7

0.71

204

1369

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

216

1411

1.02

0.09

1.8

2.0

u/l

5325.7

2365.8

0.48

478

(3003327) Ova and parasites identified in Stool by Light microscopy

862

5695

1.01

0.09

1.6

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

187

1.07

0.09

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

656

4330

1.01

0.09

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

498

0.96

0.09

1.0

1.2

umol/l

1.7

3.0

7.40

456

(3021788) Differential panel - Synovial fluid

627

4139

1.01

0.08

1.4

1.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

286

1.05

0.08

2.8

2.4

pmol/l

89.2

72.9

0.57

252

(3025577) Chromium [Mass/volume] in Blood

224

1521

0.98

0.08

1.9

2.1

ug/l

2.7

2.3

0.50

190

1260

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.09

0.08

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.09

0.08

1.0

1.1

2.4

2.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

151

986

1.02

0.07

1.0

1.1

iu/ml

11.5

9.7

0.31

212

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

638

4216

1.01

0.07

1.4

e6/l

661.9

1930.1

1.56

551

3411

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

644

4257

1.01

0.07

1.3

mmol/l

4.1

3.8

6.21

607

3998

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

320

0.96

0.07

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

235

1.05

0.07

1.2

1.4

mmol/l

10.9

9.3

1.14

122

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

200

1312

1.02

0.07

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

1087

1.02

0.07

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

274

1803

1.01

0.07

1.8

1.9

mg/l

4.9

3.9

2.45

254

1721

(40759836) Histone Ab [Presence] in Serum by Immunoblot

199

1306

1.02

0.06

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

200

1313

1.02

0.06

1.2

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

120

784

1.02

0.06

2.3

3.0

mu/l

23.7

25.3

0.16

108

733

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

348

1.04

0.06

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

200

1314

1.02

0.06

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

183

1240

0.98

0.06

1.7

2.6

e9/l

0.2

0.70

159

1093

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

244

1606

1.01

0.06

1.2

u/ml

45.3

40.6

0.13

121

(3004616) Nuclear Ab [Presence] in Serum

365

2410

1.01

0.06

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

527

1.03

0.05

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

199

1309

1.01

0.05

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

199

1309

1.01

0.05

1.2

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

243

1601

1.01

0.05

1.2

u/ml

76.7

85.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

358

0.97

0.05

1.4

1.7

ug/l

2.6

2.5

0.01

208

(36660697) Celiac disease serology panel - Serum

2059

13780

1.00

0.05

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

126

826

1.02

0.05

2.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

236

0.96

0.05

13.1

9.4

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.92

0.04

1.0

u/ml

0.0

0.2

—

(3038026) Centromere Ab [Units/volume] in Serum

250

1650

1.01

0.04

1.2

u/ml

61.8

48.9

0.20

(3041672) Baker's yeast Ab [Presence] in Serum

1.10

0.04

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.91

0.04

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

530

1.02

0.04

1.1

—

(4027681)

137

902

1.01

0.03

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

127

858

0.99

0.03

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

531

1.02

0.03

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.07

0.03

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.93

0.03

1.1

—

(4198724)

472

1.02

0.03

1.8

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

423

2835

1.00

0.02

4.4

4.8

umol/l

342.3

356.1

1.27

368

2402

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

170

1143

0.99

0.02

1.1

—

(44813793)

174

1169

0.99

0.02

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

281

1.02

0.01

2.6

2.7

u/field

0.5

0.15

281

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

104

687

1.01

0.01

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

135

1.04

0.01

1.1

u/field

1.1

0.28

(3011325) HIV 1+2 Ab [Presence] in Serum

1.06

0.01

1.0

—

(40761536) Microorganisms panel - Urine sediment

2534

16886

1.00

0.01

5.1

4.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.95

0.01

1.0

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

169

1.03

0.01

1.0

1.2

29.8

23.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

115

762

1.01

0.01

1.2

1.1

—

(3022145) Colonoscopy Study observation

3550

23687

1.00

0.00

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

538

0.99

0.00

1.2

pmol/l

354.5

283.8

0.35

386

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

538

0.99

0.00

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

114

0.99

0.00

1.0

1.1

u/l

47.9

123.2

0.63

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.01

0.00

1.4

1.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.00

0.00

1.1

1.0

u/ml

0.0

0.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

317

0.99

0.00

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

400

1.00

0.00

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

356

0.99

0.00

1.5

1.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

447

2983

1.00

0.00

2.4

2.6

u/ml

392.0

1030.7

0.87

441

2937

(3048879) Bone marrow aspiration report

110

730

1.01

0.00

1.4

1.7

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.04

0.00

1.0

u/ml

0.0

0.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

132

882

1.00

0.00

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

573

1.00

0.00

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

297

1982

1.00

0.00

1.4

1.5

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.95

0.00

1.0

u/ml

19.0

30.0

—

(40758358) Immune stain study

0.96

0.00

1.0

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.88

0.00

1.0

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.86

0.00

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.90

0.00

1.0

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

0.97

0.00

2.6

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.88

0.00

1.0

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CHD and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CHD	1.777 [1.64, 1.92]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.036

During the follow-up period (1.1.1998 — 31.12.2019), 57466 out of 120165 females with I9_CHD died.

Males

Parameter	HR [95% CI]	p-value
I9_CHD	1.503 [1.39, 1.63]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 66502 out of 176327 males with I9_CHD died.

Mortality risk

Mortality risk for people of age

years, who have I9_CHD.

N-year risk	Females	Males
1	0.155%	0.183%
5	0.94%	1.407%
10	2.199%	3.379%
15	4.095%	6.386%
20	6.943%	10.695%

Relationships between endpoints

↥

Index endpoint: I9_CHD – Major coronary heart disease event

GWS hits: 105

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Major coronary heart disease event

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints